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NEUTROPHIL DIVERSITY IN THE PATHOGENESIS OF 
 ISCHEMIC ACUTE KIDNEY INJURY 
Acute kidney injury (AKI) affects millions of patients worldwide yet has few 
treatment options. There is a critical need to identify novel interventions for AKI, especially 
approaches targeting cell types that are central to the disease, such as neutrophils. 
Neutrophils are professional phagocytic cells that respond early to tissue injury.  In rodent 
models of severe ischemic-reperfusion-injury AKI, neutrophils transiently infiltrate the 
injured kidney, appearing within 6 hours, and are gone by 72 hours. These infiltrating 
neutrophils are considered proinflammatory and harmful to tissue repair and recovery of 
kidney function. However, neutrophils can exhibit atypical activity such as antigen 
presentation and have a central role in recovery from myocardial ischemic injury. 
Furthermore, little is known of neutrophil polarization, atypical activity, or neutrophil 
diversity in AKI.  Lastly, the kidney generated and renal-protective immunomodulatory 
protein uromodulin (Tamm-Horsfall Protein, THP) regulates granulopoiesis.  In the 
absence of uromodulin, there is a systemic increase in neutrophils and mouse kidneys are 
sensitive to injury in AKI.  To elucidate neutrophil diversity in AKI and their sensitivity to 
uromodulin, I performed a series of single-cell sequencing experiments to generate 
transcriptional profiles of neutrophils from the blood and kidneys of wild-type and THP-
knockout mice after renal ischemic-reperfusion-injury (IRI).  Neutrophil diversity was 
detected following IRI of the mouse kidney in the blood and kidney.  The distribution of 
subpopulations was sensitive to the kidney milieu.  Within the kidney, this diversity and 
the transcriptional programs of neutrophil subpopulations was sensitive to the severity of 
ischemic injury.  Lastly, Cxcl3 was uniquely upregulated in specific neutrophils after severe 
ischemic injury.  Using single-cell sequencing of uromodulin knock-out mice, I detected 
the upregulation of toll-like receptor pathways and complement cascades across 
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neutrophil subpopulations in a THP sensitive manner.  Furthermore, CXCR2 ligand 
expression was a combination of moderate and severe injury in wild-type mice.  This 
confirmed previously reported cytokine dysregulation in the uromodulin knock-out mouse 
after IRI and uncovers a novel role for Cxcl3. Thus, upon revisiting the well-studied 
neutrophil, I have uncovered novel neutrophil diversity that correlates with recovery of 
kidney function in AKI and suggests new roles for an old player. 
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Introduction and Background 
 
The nature and behavior of neutrophils are central to the pathogenesis of AKI. 
Neutrophil plasticity exists in several diseases and pathologies.  There are examples of 
neutrophil plasticity and diversity in infection, autoimmunity, sterile inflammation, and 
cancer.  Some of the best characterized examples are in cancer where specific classes of 
tumors are more likely to support pro-tumorigenic neutrophils.  The plasticity of neutrophils 
in cancer has extended to the description of antigen presenting neutrophils ex vivo.  In 
AKI there has been only a limited description of diverse types of neutrophils.  In 
combination with high-resolution and high throughput transcriptomics the stage is set for 
uncovering novel cell types across the kidney parenchyma and immune cells such as 
neutrophils.  With this high-resolution data, the mechanisms behind injury and disease 
may become apparent.  
 
Acute kidney injury   
Worldwide, there are an estimated 13 million cases of acute kidney injury (AKI) 
annually(1).  In the United States there are an estimated 1.2 million cases annually or 
about twenty percent of adult patients(2-7).  AKI is estimated to have an economic cost of 
five to nine billion dollars annually(4).  Comorbidities and risk factors such as stroke, heart 
disease, diabetes and chronic kidney disease, major surgery, cancer treatment and 
common drugs exacerbate AKI(3, 8, 9).  Thus, AKI is a public health problem. 
Mechanistically, AKI causes include, drug induced nephrotoxicity and/or ischemia.  
Drug induce nephrotoxicity can lead to tissue damage included interstitial nephritis, tubular 
necrosis, glomerular injury, and changes in hemodynamics.  Common drugs that can 
cause AKI include non-steroidal anti-inflammatory drugs, angiotensin-converting enzyme 
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inhibitors, angiotensin receptor binders and chemotherapies for solid tumors such as 
cisplatin(10-12). 
Systemic, kidney and urinary tract pathologies can lead to AKI (10).  Typically, AKI 
occurs over a period of few days and includes a rapid drop in kidney function and blood 
filtration.  This can be measured by the accumulation of creatinine, a byproduct of muscle 
metabolism of creatine, in the serum and reduced urine volume.  AKI is defined clinically 
as an increase in serum creatinine above 0.3 mg/dL or 1.5x increase in serum creatinine 
levels above baseline within days and a drop of urine output to less than 0.5ml/kg over 6 
hours(3, 13).   The goal in treating AKI is to return the kidney to normal function as 
measured minimally by urine output and serum creatinine levels.  Intervention are limited 
to removing or replacing nephrotoxic drugs, maintaining blood volume and urine output 
while also providing supportive care(14, 15).  Thus, there is a need for novel interventions 
and therapeutic strategies to reduce the burden of AKI. 
The etiologies for ischemic  AKI can be grouped into three categories based on 
their origin: systemic, kidney and urinary tract(16).  Respectively, blood volume loss and 
ischemia from surgery or organ failure, occlusion of the urinary tract by kidney stones or 
cancer and ischemia and/or inflammation at the kidney can all lead to AKI.  In the kidney, 
inflammation is often localized to specific segments of the nephron-the filtering unit of the 
kidney(3, 16-19).  This includes inflammation associated with glomeruli, vasculature, renal 
tubules and the interstitium, respectively: glomerulonephritis, vasculitis and 
tubulointerstitial nephritis.  The inflammation can be an allergic reaction or nephrotoxicity.  
Non-steroidal anti-inflammatory drugs can be especially harmful with a “two-hit 
mechanism”, decreasing renal flow at the glomeruli and causing nephrotoxicity and tubular 
necrosis.  Ischemic injury also leads to tubular necrosis in the kidney and subsequent 
sterile tissue inflammation(16).  In total, the breadth and the mechanistic diversity in AKI 
is challenging.   
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Because ischemic injury is the leading cause of AKI(20), these works focus on 
ischemia and reperfusion injury (IRI) of the mouse kidney to model AKI(21).  As one might 
expect the amount of ischemia, time or degree (e.g. one or two kidneys) affects the degree 
of injury and AKI.  Specifically, In IRI, the injury time and the time after injury, reperfusion, 
can be varied.  During reperfusion there are three phases of on-going damage, recovery 
and repair depending upon the degree of injury(16).  One the earliest cell-types to arrive, 
by 6 hours, peak at 24 hours and leave by 72 hours, are neutrophils. 
 
Neutrophils and AKI 
Neutrophils make-up as much as 70% of the circulating white blood cells.  Their 
lifecycle maybe as short as hours or as long as days.  Neutrophil behaviors are diverse 
and include variable times in circulation, specific association with endothelial cells, 
regulated migration out of circulation and into tissue or margination, reverse migration to 
lymphoid tissue and the bone marrow (BM) and transcriptional plasticity(22-25).   
Neutrophils are granulocytes formed in the BM niche during granulopoiesis.  
Granulocytes are myeloid cells that share a common progenitor with mononuclear 
phagocytic cells such as monocytes, macrophages and dendritic cells.  Classically, 
granulocytes were identified by the presence of pigment reactive granules in their 
cytoplasm and their distinct nuclear morphology.  Their differentiation is tightly regulated 
by the activity of transcription factors including CCAAT/enhancer-binding proteins, PU.1 
and GATA-1.  During neutrophil maturation CXCL12 expressed on the cell surface 
interacting with CXCR4 to retain them in the BM.  Neutrophils leave the BM in a naïve 
state after the upregulation of CXCR2 on their cell surface and an increase in CXCL2 
supplants CXCL12 interaction with CXCR4.  Dendritic cells further modulate the 
distribution of neutrophils between the BM, circulation and margination into tissues 
through granulocyte colony stimulating factor (G-CSF) and the cytokines CXCL1, CCL2 
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and CXCL10.   In addition, the pro-inflammatory cytokines such as IL-1β, TNFα, and the 
growth factors G-CSF and granulocyte/macrophage colony stimulating factor (GM-CSF) 
can also drive granulopoiesis and neutrophil production and maturation.  IL-17 originating 
in sites of inflammation may drive G-CSF and further granulopoiesis.  These 
proinflammatory cytokines also shift the neutrophil from a “resting” or naïve state to a 
primed state whereby neutrophils may be recruited to sites of tissue damage, infection or 
on-going inflammation(26, 27). 
Once out of the BM, neutrophils are found in three basic locations: circulation, 
marginating under non-injury conditions and infiltrating tissue during injury.  Marginated 
pools of neutrophils are found in the lung, spleen and liver.  Neutrophil margination in the 
lung is driven by CXCL12 from endothelial cells and the neutrophil age dependent 
increase in surface expression of CXCR4.  During tissue injury neutrophils transition from 
circulatory pools to the tissue, in five distinct steps: rolling, adhesion, crawling, 
extravasation and migration within the tissue(28). 
Classically, neutrophils in circulation are thought of as early “hunter-killers” with 
specific transcriptional responses and self-destructive responses such as efferocytosis 
and NETosis (neutrophil extracellular trap-osis)(22, 29, 30).  In this model of neutrophil 
behavior, often in the context of infection, neutrophils are drawn to the site of infection via 
cytokines and pathogen associate molecular patterns (PAMPs).  Once at the site of 
infection the neutrophils generate ROS, degranulate releasing cytotoxic antimicrobial 
proteins and peptides and phagocytosis pathogens.  Once the “killing” capacity of the 
neutrophils is reached they undergo apoptosis and are phagocytosed or efferocytosed by 
macrophages.  Neutrophil extracellular traps are the most severe example of a 
neutrophil’s self-destructive potential(31).  In NETosis PAD4 citrullinates histones driving 
DNA decondensation.  The decondensing DNA breaks out of the nucleus and spills out of 
the cell.  This net of DNA is thought to trap pathogens and limit infection.  In AKI, this is 
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considered a deleterious process as inhibiting PAD4 or treatment with DNase improves 
renal function after IRI(31-33).  Presumably, this is because tissue damage is limited, 
minimizing fibrosis and loss of functional nephrons.  Although these classic behaviors 
dominate our model of neutrophils, growing evidence suggests that neutrophils are more 
nuanced and exhibit phenotypic plasticity and heterogeneity or, at the least, significant 
transcriptional activity in response to infection and tissue injury. 
There are several striking examples of neutrophil phenotypic heterogeneity and 
plasticity(22).  One of the best characterized examples of phenotypic heterogeneity in 
neutrophils is found in cancer(34-38).  Tumor associated neutrophils (TANs) have been 
classified as either N1 (anti-tumorigenic) or N2 (pro-tumorigenic) neutrophils.  The 
cytokine and growth factor TGFβ, is sufficient for a transition to the immunosuppressive 
N2(34).  Strikingly, the N2 phenotype is often found at the center of the tumor-presumably 
where the TGFβ concentration is highest(39).  An important recent finding is that, in vitro, 
this transition involves transcriptional reprogramming, suggesting that the N2 is a bona 
fide type of neutrophil(36).  Thus, neutrophil polarization occurs in response to specific 
cytokines and polarized N2 neutrophils localize within the core of the tumor and are pro-
tumorigenic. 
 
Ischemic injury models and neutrophil polarization   
  N1 and N2 polarized neutrophils also have roles in ischemic injury of several 
organs.  This includes ischemic injury of the brain, heart and kidney. In brain and heart 
there appears to be a role in recovery and repair for neutrophil polarization.  The role of 
neutrophil polarization in AKI is less clear. 
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Neutrophil polarization following myocardial infarction.   
In myocardial infarction (MI) there is a clear temporal regulation of neutrophil 
polarization(40).  In the days immediately after MI, in response to DAMPs, a 
proinflammatory milieu is formed occupied primarily by N1 neutrophils.  By five days post 
MI the site of injury transitions to an anti-inflammatory milieu; IL1 and TNF drop and IL-
10 increases with a concomitant increase in N2 and decrease in N1 neutrophils.  This 
transition correlates with better outcomes and less long-term damage (thinning of the 
ventricle).  It is unclear whether the polarization to an N2 phenotype occurs only at the site 
of injury.  Although, the authors did not detect N2 neutrophils in circulation.  The author’s 
also present data suggesting the mannose receptor, CD206, also a marker for M2 
macrophages, may be a marker for separating N2 from N1 neutrophils by flow cytometry. 
 
Neutrophil polarization in areas of injury following stroke.   
While investigating the mechanism behind the beneficial of a PPAR agonist in 
treating (a driver of M1 to M2 macrophages switches), Cuartero and colleagues discover 
a distinct polarization of neutrophils, based on the M2 markers CD206 and Ym1, by flow 
cytometry and immunofluorescence(41).  In their model of stroke, permanent middle 
cerebral artery occlusion (pMCAO), ~30% of the infiltrating neutrophils are Ym1+ and 
CD206+.  Importantly, there were nearly no N2 neutrophils by either marker in a sham 
treated group further supporting my hypothesis that the milieu drives neutrophil 
polarization. 
 
Polarized N2 neutrophils are found in AKI.   
In a 2018 study to understand the impact of cannabinoids on AKI, N2 neutrophils 
were found in the kidney after IRI using the putative N2 marker CD206(42, 43).  In this 
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work the authors show that equal proportions of N1 and N2 neutrophils is required to 
minimize KIM-1+ tubular injury.  Unique to this work is the detection of equal numbers of 
N1 and N2 neutrophils in the uninjured and injured milieu 24 hours after surgery.  In other 
models of ischemic injury, myocardial infarction and stroke only ~20% of neutrophils were 
N2 polarized during the recovery phase(40, 41).  Also contrary to the other ischemic injury 
models, the fraction of N2 neutrophils following a Sham surgery were high-they were 
nearly undetectable in stroke.  This suggests either a unique milieu exists in the kidney or 
that the models of ischemic injury differ greatly. For instance, in these studies of AKI, they 
used a mouse model of moderate injury with an ischemic injury time of 20 minutes.  The 
large fractions of N2 neutrophils in the sham surgery is perplexing.   It is unclear what role 
the severity of injury is playing in the degree of neutrophil polarization and neutrophil 
diversity in ischemic injury of the kidney, warranting further investigation. 
 
The response of neutrophils is early and swift in ischemic AKI.   
In wild-type mouse models of ischemic AKI neutrophils are detected as early as 
30 minutes after injury(18, 44, 45).  The peak of infiltration occurs between 24 and 48 
hours and by 72 hours the infiltration has subsided.  Recovery of kidney injury with 
moderate injury is seen by one-week post injury(46).  Arguably the microenvironments 
formed by 24 hours is a direct consequence of the conditions that have been developing 
for hours.   
 
Neutrophils persist in depletion and inhibitory experiments.     
An important consideration, with respect to depletion and drug-based interventions 
is that often the improvement in kidney function is not necessarily in a kidney devoid of 
neutrophils.  Although early works on ICAM-1 confirms the depletion with less that 100-
200 neutrophils per mm3 in their experiments, it is unclear whether this was based on 
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cortical or medullary assessments(47).  Furthermore, other experimental interventions, 
inhibitory or chemokine depletions, often have residual neutrophil levels not 
investigated(32, 45, 48).  Could these interventions bias the kidney milieu to a reparative 
neutrophil?  This suggests a high-resolution assessment of the types of neutrophils is 
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Chapter 1.  The cellular map of 129Sv/Ev mouse kidney 
 
Introduction 
Identification of critical cellular players involved in diseases, especially those as 
complicated in their etiology as acute kidney injury (AKI) is difficult with directed 
approaches, such as antibody based multiplexing techniques used in 
immunofluorescence and flow cytometry.  Although the depth of these approaches has 
improved greatly over the last decade now permitting up to 30 markers, they are still based 
on the assumptions made about specific markers for cell subtypes and confined by 
identification through gating strategies.  Methods that combine a regional isolation of 
tissue structures, such as laser microdissection, with RNASeq enhance the depth of the 
cellular players involved in disease while maintaining tissue context but compromise the 
breadth of cell-types by assaying regions containing many cells(49, 50).  Importantly, the 
context of a cell is critical for understanding the biology and physiology of an organ-
especially an organ as structurally diverse as the kidney.  Single cell RNASeq, provides 
the best breadth and depth for cell identification at the cost of this contextual metadata(51). 
Single cell RNASeq has been used previously to identify cell types in the mouse 
kidney(52, 53).  In these publications a major limitation has been the recovery of 
leukocytes.  To address this problem, a combination of whole kidney isolation (poor 
recovery of leukocytes), CD45+ enriched isolation (excellent recovery of leukocytes) and 
Blood isolation (excellent recovery of circulating leukocytes) were tested and used. 
The overarching hypothesis is that in AKI the populations of neutrophils present in 
the injured kidney dictate the recovery of kidney function.  To capture cellular diversity with 
scRNASeq two complimentary approaches for isolation of single cells were tested: 1) an 
approach for isolating all cells of renal parenchyma and 2) an approach to enrich 
leukocytes associated with kidney.  These complimentary approaches demonstrated 
   
10 
 
diversity in the kidney parenchyma and in immune cells, specifically tubular epithelium or 
macrophages and neutrophils.  The data presented here demonstrates that there are 




Quality of single cell RNAseq and basic processing of datasets 
Single cell RNA sequencing (scRNASeq) has been used to build single cell RNA 
transcript-based models of development, organs and disease(54-60).  To develop a 
cellular map of kidney in the mouse strain 129Sv/Ev, whole kidneys from wild-type (WT) 
mice were processed with a MACs isolation kit to liberate single cells suitable for droplet-
based scRNASeq.  To facilitate comparison with experiments that involve surgeries, the 
body cavity was opened and closed to mimic a surgery such as bilateral clamping of the 
kidney pedicule (see Chapter 4).  cDNA libraries were generated, sequenced, and aligned 
as described in methods.  The resulting expression matrix was analyzed in R using 
Seurat(61).   
To generate a dataset appropriate for downstream analysis the quality of the per 
cell libraries was assessed.  In droplet-based scRNASeq there is a possibility of multiple 
cells being incorporated into one droplet resulting in a library that contains cDNA from 
more than one cell.  The increase in cDNA can lead to a library with aberrantly high read 
counts following sequencing.  Conversely, cells with a low read count suggest a dearth of 
cDNA and possibly a damaged or dying cell.  Furthermore, cells with a compromised 
plasma membrane will have fewer cytoplasmic mRNA and their libraries will be over-
represented by mitochondrial RNA.  To quality control the cDNA libraries, libraries from 
whole kidney with high or low read counts or if the fraction of total mitochondria transcript 
reads was greater than 50% of the total reads were excluded from the analysis ((59)Figure 
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1.1).  For libraries from cells enriched for immune cells, a more stringent 5% mitochondria 
fraction of total transcript reads was used(61, 62).  The number of times a cDNA is 
sequenced is used as the measure of transcript abundance.  However, it is not uncommon 
for all cDNAs to be low across a single cell-due to variations in library generation.  To 
correct for this variation, read counts were normalized with Seurat’s Log normalizing 
approach(61).   
To identify cell types, there needs to be enough genes with high enough variance 
to elaborate an expected number of cell types.  With a dataset from a sham surgery in WT 
mice and whole kidney isolation of cells, the top 10 highly variable genes include markers 
for neutrophils and epithelial cells suggest adequate complexity in the read counts and 
hence cells (Figure 1.2).  To cluster and identify the cells represented by the read counts 
30-40 principal components were determined from the normalized read-counts.  To 
assess how many principal components to use for clustering an elbow plot or JackStraw 
process were performed (Figure 1.3).  These principal components were used for 1) 
clustering the cells into populations and 2) visualization directly or with dimensionality 
reduction (Figure 1.4).  
 
The cellular composition of 129Sv/Ev mouse kidneys 
To establish a map of the mouse kidney, cells from wildtype mice after a sham 
surgery were analyzed from a combined dataset (see methods, Figure 1.4A).  Using a 
combination of SingleR, and published markers the major cell types were identified ((63) 
Figure 1.5).  The major epithelial cells of the nephron were identified.  Furthermore, the 
specialized smooth-muscle cells, granular cells, of the juxtaglomerular apparatus were 
identified.  The recovery of immune cells was poor, making it difficult to described immune 
cell subtypes and diversity (e.g. <30 putative macrophages, T-cells or neutrophils were 
recovered-outlined below).   
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Epithelial cells of the proximal tubule subsegments 
The proximal tubule has been previously described into the three major segments, 
S1, S2 and S3 where S1 and S2 are a part of the proximal convoluted tubule and S3 is a 
linear tubule often found in medullary rays.  These three segments have been classified 
by scRNASeq previously(59). Surprisingly, the epithelial cells of all three subsegments of 
the proximal tubule could be further subdivided with the S1 being composed of three 
distinct cluster (clusters 1,6 and 13, Figure 1.4), S2 comprised of two distinct clusters 
(clusters 4 and 7, Figure 1.4) and the S3 could be divided into three sub clusters (clusters 
3, 8, 19, Figure 1.4).  One of the S3 sub clusters (cluster 3) is reminiscent of the type 2 
S3 proximal tubule cells (53).   
 
Epithelial cells of the distal nephron  
The distal nephron was also well represented in the disaggregated cells of the 
mouse kidney.  There were clusters of cells identified as being from the loop of Henle 
(LOH), distal convoluted tubule (DCT), collecting network tubules (CNT) and collecting 
ducts (CD).    Distal to the DCT is the cortical connecting tubule network.  In these data it 
is found bridging the subsegments of distal tubules (Figure 1.5).  Previously described 
markers were used to identify epithelial cells of the CD including principal cells (CD-PC 
and two population of intercalating cells (CD-ICa and -ICb) were identified in the data 
((59)Figure 1.4B and 1.5).   
 
Endothelium and associated cells 
An Endothelium cluster was identified that was comprised of multiple clusters-
however a clear identification of subtypes could not be made.  Furthermore, podocytes, 
by Nphs expression(52), are missing from the dataset.  Although critical to acute 
glomerular nephritis and linked to septic-AKI, the role for podocytes in ischemic AKI is not 
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clear(64).  Using Ren1 the mouse gene for renin, a single cluster in UMAP space was 
highlighted, suggesting these were the specialized secretory smooth-muscle cells of the 
juxtaglomerular apparatus (Figure 1.6). 
 
Leukocytes 
The protocol used for isolation of cells from the disaggregated kidneys did not 
include specific steps for enrichment of immune cells.  It was thus unlikely that significant 
number of immune cells would be captured.  This was the case as small numbers of 
presumptive circulating neutrophils, B-cells, T-cells and NK cells were identified as well as 
few macrophages (Figure 1.4B and 1.5). 
 
Isolation and CD45+ enrichment of immune cells 
To address the poor recovery of immune cells from whole kidney isolation, a 
CD45+ enrichment approach was used. The enrichment protocol used density 
centrifugation and sorting with fluorescence activated cell-sorting of CD45 labeled cells.  
The density centrifugation was originally designed to enrich for neutrophils and was 
adapted here to enrich multiple types of immune cells (65)(Figure 1.7A).  This approach 
was first proven by flow cytometry and used to generate single cells for sequencing 
(Figure 1.7B).   
To establish a distribution of immune cell types in the mouse kidney, single cells 
for scRNASeq were isolated and enriched from whole kidneys.  In the unchallenged 
kidney, a sham surgery, six kidneys from three mice were pooled to ensure an adequate 
yield of leukocytes.  Data used here was from cells that had been integrated into a 
combined dataset (see methods).  20 clusters were identified spread across three groups 
in a UMAP plot (Figure 1.8A).  Cell-types were classified by cluster with identification by 
SingleR, manually based on published markers and/or following differential expression 
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analysis (Figure 1.8B and 1.9).  In contrast to the whole kidney isolation, the use of a 
centrifugation and CD45+-cell sorting step increased the recovery of lymphocytes-
including subclasses of T-cells and myeloidal cells-including eosinophils, dendritic cells, 
macrophages and a monolithic cluster of neutrophils (Figures 9 and 1.8B).   
Relative to immune cell recovery from the whole kidney isolation protocol, 
macrophages and lymphocytes saw some of the greatest increase in number and breadth 
of cell-types.  Initially there was a small cluster T and NK cells and a small cluster of B 
cells in the whole kidney preparation (Figure 1.4B and 1.5).  After isolation and 
enrichment, T-cells were readily subclustered into CD8+ (cytotoxic T-cell), CD4+ (T-helper 
cell) and regulatory T-cells.  Both NK and B cells were also isolated by the enrichment 
protocol (Figures 1.4B and 1.5B).  Like T-cells, the number and breadth of macrophage 
types was striking with multiple clusters including putative monocyte macrophages.   
To explore sub-populations of the subtypes of macrophages and neutrophils, these 
cells were isolated from the CD45+ enriched dataset for further analysis.  As kidneys were 
not perfused prior to isolation of single cells, cells are expected to include immune cells 
that have marginated, those that have extravasated into the interstitium and cells in the 
blood.  Thus, in a sham surgery we expect to detect a significant number and depth of 
most leukocytes originating from cells in the blood and kidney.   
 
Monocytes and macrophages of the mouse kidney   
Recent work has described three populations of macrophages in the mouse 
kidney- two infiltrating monocyte/macrophages and a third resident macrophage(60).  
These three types of macrophages were identified using the markers Plac8 for infiltrating 
monocyte/macrophages, Ear2 and Chil3 for either Ly6chi and Ly6clo 
monocyte/macrophages respectively and Cd81 for resident macrophages.  These three 
populations were readily identified in the CD45+ enrichment isolation (Figure 1.10A).  
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There were also an additional three populations of monocyte/macrophages identified.  
These included a population similar to the Ly6chi macrophages but also expressing 
Stmn1, a marker of inactivation (Macrophage-Ly6chi-inactivated), and a two additional 
monocyte/macrophage populations that expressed Plac8, but not Ear2 or Chil3, 
suggesting two additional infiltrating population of monocyte/macrophage (Monocyte-1 
and Monocyte-2, Figure 1.10B and C). 
 
Populations of neutrophils 
To explore neutrophils subpopulations, neutrophils were first isolated from the 
CD45+ enriched dataset (sham surgery in WT mice).  Because the neutrophil cluster was 
monolithic (Figure 1.8B), new principal components and clusters were determined.  
Following clustering, four distinct populations were identified (Figure 1.11). Differential 
expression (DE) analysis was performed to determine markers (p < 0.05, Bonferroni 
corrected) and possible functional characteristics for these populations (Figure 1.12).  A 
highly and uniquely expressed marker could not be identified for Cluster 0-as if it were a 
parent cluster.  Cells in this cluster were highly expressing the neutrophil markers S100a8 
and S100a9.  There were two differentially expressed transcripts identified in cluster 2, the 
proinflammatory cytokine Il1b and the secretory granule associated protein Sgrn.  
Although more robustly expressed in cluster 0, both transcripts are found, expectedly, in 
multiple neutrophil populations (Figure 1.12).  Fortunately, the remaining clusters had 
unique markers identified by DE analysis.  Cluster 1 was uniquely identified by two poorly 
characterized, yet proteins common to neutrophils, cystatins (Gm5483 and BC100530). 
This suggests cluster 1 may be a motile neutrophil population(66).  Cluster 3 markers 
included Lgals3 and Retnlg.  Retnlg may be a regulator of neutrophil activity, suggesting 
either a regulated and/or regulating neutrophil(67).   
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It is possible that myeloid derived suppressor cells (MDSC) may have been 
clustered erroneously in the neutrophil population.  To test for this possibility, 
transcriptomics markers of granulocyte myeloid derived suppressor cell (G-MDSC) were 
investigated (Cd84 and Arg1, Figure 1.12).  The 4 putative neutrophil clusters were 
positive for typical neutrophil markers (S100a8 and S100a9) but negative for markers of 
G-MDSCs (Cd84 and Arg1)(60). 
 
Discussion 
The two single cell isolation protocols complement each other with cell-type 
specific sensitivity and specificity.  Having both approaches will be critical to uncovering a 
better and deeper model of what is transpiring during AKI-especially the role of diverse 
types of leukocytes such as neutrophils.   
 The ability of scRNASeq to uncover transcriptional diversity was illustrated in both 
cell isolation protocols.  The whole kidney approach without enrichment (whole kidney 
isolation) was able to uncover the proximal tubule subsegments.  In the CD45+enriched 
preparation (CD45+ enrichment isolation) the T-cell, macrophage and neutrophil clusters 
had improved depth.  T-cells separated into putative CD4+ and CD8+ clusters and 
macrophages were easily divided into infiltrating and resident clusters.  Additionally, T-
regs were resolved and several additional novel subtypes of infiltrating macrophages were 
uncovered.  In total, the CD45+ enrichment protocol is a better approach for uncovering 
breadth and depth of immune cells.   
After separating the neutrophils from the remainder of CD45+ cells, four putative 
subpopulations of neutrophils were identified.  These included specific neutrophil subtypes 
that may be uniquely motile, antigen presenting or classically activated.   Furthermore, 
these behaviors are highlighted by specific markers that may be used moving forward for 
cluster identification.  It is reassuring that some of these behaviors have been described 
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previously(68, 69). Importantly, this is the first report of an unbiased census of neutrophil 
subtypes in or associated with an organ-in this case the kidney.   
Neutrophil diversity has been studied in the context of infection, injury and cancer.  
In AKI it is expected that neutrophil diversity will expand and change.  For instance, the 
tubular epithelium may drive neutrophil recruitment in unexpected ways or specific 
neutrophil subpopulations may be the sole source for signaling.  There may be 
subpopulations of those presented here or completely novel populations all responding to 
tissue damage and changes in cell signaling within the kidney milieu. 
 
Methods   
Animals and surgeries   
All mice were treated and cared for based on approved animal handling and 
surgery protocols as outlined in Chapter 4.  Only sham surgeries are used in this chapter.  
 
Kidney dissociation and isolation of single cells   
The protocol used for kidney dissociation was provided by Janosevic et al.(70).  
Briefly, both kidneys from one male 129Sv/Ev mouse were removed after a sham surgery 
and minced together on a glass petri dish into ~8 pieces total and placed in Miltenyi Biotec 
tubes (C-tubes) with tissue digestion mix from the Multi Tissue Dissociation Kit 2 (Miltenyi 
Biotec) and agitated by a gentleMACs Dissociator (Miltenyi Biotec) followed by rotation on 
the MACSMix Tube Rotator (Miltenyi Biotec) for 30 minutes at 37°C and a final agitation 
cycle on the gentleMACs Dissociator.  RPMI+5% BSA was added to quench the enzymatic 
reactions and the suspension was passed through a 40 µm strainer that was washed with 
5 mL RPMI with 0.04% BSA.  The eluent was passed through a second 30 µm strainer 
and wash with 5 mL of RPMI with 0.04% BSA.  The total eluent was centrifuged at 300 x 
g for 5 minutes at 4°C and the pellet resuspended in 1 mL chilled RBC Lysis Buffer (Sigma) 
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and incubated for 5 minutes at 4°C.  10 mL cold RPMI with 0.04% BSA was added to 
dilute the lysis buffer and the sample was spun at 1000 rpm in a tabletop centrifuge at 4°C 
(Eppendorf 5430).  The cells were washed three times with 5-minute spins to pellet the 
cells.   After the final wash the pellet was resuspended in 1 mL of cold RPMI with 0.04% 
BSA.  Dead cells were removed from the suspension using the EasySep Dead Cell 
Removal by Annexin V Kit (Stemcell Technologies).  The magnetic beads were isolated 
using a multi-tube magnet for 1.5 mL tubes (Invitrogen).  After removal of the dead cells 
the cell suspensions were transferred to 15 mL conical tubes and centrifuged at 1200 rpm 
in the Eppendorf 5430 tabletop centrifuge at 4°C.  The cell pellet was resuspended in 1-3 
mL of RPMI with 0.04%.  This suspension was handed off to the genomics core for 10x 
processing.  
 
Kidney dissociation and enrichment of CD45+ leukocytes 
Both kidneys from four male 129Sv/Ev mice (eight kidneys total) were removed 
following a sham surgery and both pairs of kidneys placed in two separate Falcon 12 x 75 
mm tubes with 1 mL iced Hank’s balanced salt solution.  Kidneys were homogenized with 
a Tissuemiser on ice by making 10 passes three times.  The tissue slurry was incubated 
with collagenase type IA for 30 min at 37°C in a water bath.  To clarify the slurry the 
suspension was passed through a 70 µm strainer into a 50 mL centrifuge tube.  The 
strainer was washed with a total of 14 mL PBS+1% fetal bovine serum (FBS).  The eluent 
was centrifuged at 2000 rpm for 10 min (~1,600 x g) and the supernatant removed.  To 
remove red blood cells and cellular debris the suspension was clarified on a Percoll 
gradient(65).  Room temperature and sterile Percoll was prepared at 100% and either 
diluted to 40% or 70% in 1x PBS+1%FBS.  At room temperature, the cell pellet was 
resuspended in 8 mL of the 40% Percoll in 1xPBS+1%FBS and layered on top of 3 mL of 
70% Percoll in 1x PBS+1%FBS at room temperature.  The gradient was spun for 30 
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minutes at 900 x g at room temperature.  The centrifuge brake was turned-off to not disturb 
the formed gradient and separated cells.  Following the spin there was a fatty cellular 
debris layer at the top of the gradient, a fuzzy “buffy coat” at the interface between the 
40% and 70% Percoll, a thin band of red blood cells just below that and a pellet of red 
blood cells.  The buffy coat was removed and diluted to 15 mL with PBS+1%FBS and 
spun at 800 x g for 10 min at 4°C.  After removing the supernatant, the pellet was 
resuspended in 1 mL PBS+0.1%FBS.  In preparation for labeling with CD for sorting by 
the flow cytometry facility, the suspension was centrifuged and resuspended in 100 µL to 
which CD16/32 antibody (BDBioscience) was added and incubated for 5 minutes at room 
temperature to block Fc gamma receptors.  To label the cells with CD45 antibody, 10 µL 
(1.5 µg) APC conjugated CD45 antibody (clone 30F11, Miltenyi) was added to the 100 µL 
suspension and incubated for 30 minutes at 4°C.  Centrifuge for 1 minute at ~6000 x g 
and remove supernatant.  Resuspend both pellets (from each mouse) in 300 µL PBS+FBS 
and add 300 µL of 2x working concentration of propridium iodide (PI).  The suspensions 
from both mice were combined prior to sorting.  The sorting was carried out in the flow 
core.  Briefly, the PI was used to gate on live cells and APC on our cells of interest 
(leukocytes).  The sorted cells were collected on ice and taken to the genomics core for 
processing on the 10x platform v1.   
 
Flow cytometry of immune cells isolated by differential centrifugation   
Cell isolated by differential centrifugation were blocked with CD16/32 antibody 
(BDBioscience) and stained for FITC-CD11b, APC-Cy7-Ly6G and PE-CD45 for 30 
minutes.  After washing the cell suspension was stained with a 2X working concentration 
of PI.  Single stained mouse bone marrow cells were used for controls to calibrate the flow 
cytometer and adjust compensation matrices.  Bone marrow was extracted from the femur 
of adult mice, washed and split into four stains for CD11b, Ly6G, CD45, and PI.  A fifth 
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sample was used as an unlabeled control.  Samples were run on a Guava benchtop flow 
cytometer (Millipore).  Results were saved and processed with FlowJo (FlowJo LLC).   
 
Staining of tissue sections   
Mouse kidney fresh-fixed in 4% paraformaldehyde for 24 hours were cut into 50 
µm sections and stored at 4°C.  For staining sections were washed in 1XPBS 3-5x and 
blocked in blocking buffer, 1XPBS, 0.1% Triton X-100 and 5-10% normal goat serum 
(Jackson Immunology), for 5-30 minutes.  Primary antibody was prepared in block and 
stained overnight in a sealed container.  Primary antibodies used included anti-Ly6G 
(clone 1A8, Biolegend) and anti-KIM-1 (cat#AF1817, R&D Systems).  Following labeling 
with primary the sections were rinsed in 1x PBS 3-4x and washed in blocking buffer for 
~30 minutes 2-3 times.  Secondary antibodies with DAPI and OregonGreen488-phalloidin 
were prepared and sections were stained overnight in a sealed container.  Sections were 
rinsed and wash as above and mounted in ProLong Glass under a #1.5 coverglass.  The 
mount was cured for 48-72 hours prior to sealing with nail-polish.   
 
Confocal large-scale imaging of tissue   
Imaging was performed on a Leica SP8 upright confocal microscope with a 
motorized stage, 2 HyD and 2 PMT detectors with 4 lasers at 405 nm, 488 nm, 552 nm 
and 635 nm controlled by LASX software.  Automated tile scanning and mosaic imaging 
was performed in four channels to cover the whole tissue in x, y, and z.  The captured 
volumes were stitched in LASX and visualized in Fiji  (71, 72). 
 
Single cell 3’ RNA-seq 
Single cell 3’ RNA-seq experiments were conducted using the Chromium single 
cell system (10x Genomics, Inc) and Illumina sequencers at the Center for Medical 
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Genetics of Indiana University School of Medicine. Each cell suspension was first 
inspected under microscope for cell number, cell viability, and cell size. Depending on the 
quality of the initial cell suspension, the single cell preparation included centrifugation, re-
suspension, and filtration to remove cell debris, dead cells and cell aggregates. Single cell 
capture and library preparation were carried out according to the Chromium Single cell 3’ 
Reagent kits V2 or V3 User Guide.  Appropriate number of cells were loaded on a multiple-
channel micro-fluidics chip of the Chromium Single Cell Instrument (10x Genomics) with 
a targeted cell recovery of ~10,000. Single cell gel beads in emulsion containing barcoded 
oligonucleotides and reverse transcriptase reagents were generated with the v2 or v3 
single cell reagent kit (10X Genomics). Following cell capture and cell lysis, cDNA was 
synthesized and amplified. Illumina sequencing libraries were then prepared with the 
amplified cDNA. The resulting libraries were assessed with an Agilent TapeStation or 
Bioanalyzer 2100.  The final libraries were sequenced using a custom program on Illumina 
NovaSeq 6000. 26 or 28 bp of cell barcode and UMI (unique molecular indices) 
sequences, and 91 bp RNA reads were generated.  
 
Analysis of scRNA-seq sequence data  
CellRanger 2.1.0, 3.0.2 or 3.1.0 (http://support.10xgenomics.com/) was used to 
process the raw sequence data generated. Briefly, CellRanger used bcl2fastq 
(https://support.illumina.com/) to demultiplex raw base sequence calls generated from the 
sequencer into sample-specific FASTQ files. The FASTQ files were then aligned to the 
human reference genome mm10 with RNA-seq aligner STAR. The aligned reads were 
traced back to individual cells and the gene expression level of individual genes were 
quantified based on the number of UMIs detected in each cell.  
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Analysis of expression matrices  
The R package Seurat(61), was used extensively in the analysis of the expression 
data.  In general, the processing included loading, quality control (outlined in results), 
normalization, alignment of multiple datasets to enable comparisons between conditions 
(batch correction), clustering and visualization.  QC parameters were set based on the 
sample being isolated.  In the whole kidney isolation, immune cells were first subject to 
the less stringent %-mitochondrial QC parameter as all other cells (50%).   Immune cells 
were reprocessed with a more stringent cut-off appropriate for immune cells (5%,  (61)).   
Cell types were identified by SingleR(63) or based on literature review.  In the cases of 
neutrophils and macrophages a recursive clustering analysis was performed to resolve 
subpopulations. 
 
Combined dataset of cells from single cell isolation protocols   
To facilitate future comparisons between treatments and conditions for scRNASeq 
datasets from all AKI interventions (Chapter 2) and THP genetic models (Chapter 3) were 
combined into one dataset by single cell isolation protocol-CD45+ enrichment isolation or 
whole kidney isolation.  With this approach batch effects are managed by alignment of 
normalized expression levels by cell across all the conditions.  These integrated values 
provide the basis for principal components used in both the generation of clusters and 
dimensionality reduction.  Thus, cluster definitions are assigned across datasets and can 




 Raw and processed data will be made available online at GEO hosted by the 
National Center for Biotechnology Information. 




Figure 1.1.  Initial quality control metrics.  Total cells were isolated from sham surgery 
kidneys, processed on the 10X Chromium platform, libraries sequenced using next 
generation sequencing, reads mapped to genes and expression tables by cell created.  
The expression tables were imported into the R package Seurat v 3.1 and the percentage 
of mitochondrial reads calculated.   The number of RNAs detected (nFeatures_RNA), the 
number reads per RNA (nCount_RNA) and the percentage of mitochondrial reads 














Figure 1.2.  Detecting the variable genes for use in calculating principal 
components.  After applying QC parameters, the average expression of a gene was 
plotted versus its variance across all cells.  The top ten genes most highly variable genes 
are annotated.  The annotated genes can be broken into renal epithelial cells (e.g. Aqp6, 













Figure 1.3. Elbow plot of principal components.  An Elbow plot of the standard 
deviation of the whole population that is covered by each principal component (PC).  In 
this example using 20-30 principal components for downstream clustering and 












Figure 1.4. Clustering and dimensionality reduction of kidney scRNASeq data.  Cells 
from whole kidney were isolated and processed for 10X chromium library generation, 
sequenced, and processed as indicated in the methods.  Individual cells have been quality 
controlled, removing high count libraries/cells and those with excessive mitochondrial 
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transcripts.  A. Clustering identified 27 populations of cells.  B. Markers for cell-types found 
in the mouse kidney were collated and used to identify all clusters.  A putative cluster of 
secretory granular cells of the juxtaglomerular apparatus was identified (cluster 23, Gran. 
Cells). One novel cell-type was not identified.  The expression of Aqp1 suggests this may 









Figure 1.5. Identifying cell types in whole kidney using published markers.  Markers 
for cell-types found in the mouse kidney were collated and used to identify all clusters. 
Expression level is by color and the fraction of cells expressing the gene is indicated by 
the size of the dot (scales included). 
 
   
29 
 
Figure 1.6.  Identification of granular cells of the juxtaglomerular apparatus.  Using 
Ren1 expression, a small cluster of cells was identified as the specialized secretory 
smooth-muscle cells of the juxtaglomerular apparatus (Gran. cells).  The cells expressing 
Ren1 are highlighted by expression level, in red, and indicated with the red arrowhead. 
 






Figure 1.7. Differential centrifugation for isolation of immune cells from whole 
kidneys.  Cells were enzymatically disaggregated and separated on a Percoll gradient.  
The cells were isolated from the buffy coat, stained with antibody against CD45 and 
purified by fluorescence activated cell sorting.  A.  Example of buffy coat cells were 
isolated from (red arrow heads).  B.  Flow cytometry of the isolated cells.  Cells from buffy 
coat were stained for CD45, CD11b and Ly6G and run on a benchtop Guava flow-
cytometer.  Results were analyzed and plotted in FlowJo.  Gates and percentages are 
indicated.   
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Figure 1.8. Clustering and dimensionality reduction of CD45+ enriched scRNASeq 
data.  Cell from whole kidney were disaggregated and separated by differential 
centrifugation and CD45+ FACS for processing with 10X Chromium to generate libraries, 
sequenced and processed as indicated in the methods.  Individual cells have been quality 
controlled, removing high count libraries/cells and those with excessive mitochondrial 
transcripts.  A. Clustering identified 19 cell populations. B. Markers for cell-types found in 
the mouse immunes were collated and used to identify all clusters.   







Figure 1.9.  Identifying cell types in the CD45+ enrichment isolation using published 
markers.  Markers for mouse immune cells were collated and used to identify the clusters 
identified by Seurat.  The major immune cell classes were identified including neutrophils, 
subpopulations of mononuclear phagocytic cells (monocytes, macrophages and dendritic 
cell) and lymphoid cells.  Expression level is by color and the fraction of cells expressing 
the gene is indicated by the size of the dot (scales included). 
 




Figure 1.10.  Subdividing monocytes/macrophages into resident and infiltrating 
populations.  The putative macrophage clusters were isolated from the combined dataset 
and markers for the sub-population defined with Seurat.  A.  Feature plots of gene 
expression as indicated to subdivide the cells into infiltrating Ly6chi and Ly6clo 
monocyte/macrophages and tissue resident macrophages.  B.  Expression level per 
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markers for infiltrating versus resident macrophages.  C.  Markers for novel populations 
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Figure 1.11.  Four neutrophil subtypes identified in wild-type mice after sham 
surgery.   Cell from whole kidney were disaggregated and separated by differential 
centrifugation and CD45+ FACS for processing with 10X Chromium to generate libraries, 
sequenced and processed as indicated in the methods. Neutrophils were classified by 
S100a8, S100a9 and Ly6g and copied to a new dataset and in which principal components 
were calculated, clustered, and projected into UMAP space.  There were four clusters of 














Figure 1.12. Markers of neutrophil subpopulations identified in wild-type mice after 
a Sham surgery.  scRNASeq was performed as described in the methods on cells 
isolated from uninjured kidneys and enriched by CD45+ FACS.  Marker genes were 
identified using differential expression analysis in Seurat and curated here with expected 
neutrophil markers (S100a8, S100a9 and Ly6g), neutrophil activity markers (Ngp, Mmp8 
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Chapter 2. Neutrophil diversity and cellular census of kidneys after ischemic injury 
 
Introduction 
AKI and early immunological responses.   
Neutrophils and NKT cells are the earliest immune cells recruited to the kidney 
following IRI(3, 17, 19).  Neutrophil recruitment is CXCL2(MIP-2) dependent(48).  Once in 
the kidney, neutrophils can undergo NETosis (neutrophil-extracellular-trap-osis) 
contributing to tubular necrosis(18, 32, 33, 73).  NETosis is a regulated expelling of 
uncondensed DNA from neutrophils to trap damage and pathogens associated molecular 
patterns (DAMPs and PAMPs) at sites of infection and injury(31, 74). Consistent with this 
finding, depletion of neutrophils or inhibiting NETosis reduces tubular necrosis and plasma 
creatinine levels 24 hours after injury(32, 48).  Importantly, the work on NETosis in AKI 
has used severe injury models (28-35 min IRI) predominantly in C57BL/6 mice.  After 
severe injury in C57BL/6 mice, there is poor recovery of kidney function and acute 
mortality suggesting extreme kidney injury and kidney failure in these models(32, 33).  
Thus, the immunological processes in these models reflect an extreme.  The role of the 
severity of injury in modulation of neutrophil biology during AKI is poorly understood.  In 
our work we have shown that in our model of moderate injury (22 minutes ischemia) in 
129Sv/Ev (wt, taconic) mice, we can model moderate AKI(46, 75).  This is indicated by an 
elevated serum creatinine (~2x baseline at 24 hours), the presence of infiltrating 
neutrophils in the kidney, cast formation in renal tubules and tubular necrosis.  
Furthermore, in our model of severe injury (30 minutes ischemia), we observe further 
elevated serum creatinine (~10x baseline at 24 hours), an increase in neutrophil infiltrates 
and increased numbers of casts and tubular necrosis(21, 75).  Importantly, in this severe 
model, serum creatinine levels return to baseline after 1 week indicating recovery of renal 
function.  Thus, these two models can be used to understand the impact of the severity of 
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injury.  I hypothesized that the severity of injury dictates the types of neutrophils recruited 
to the kidney to shape recovery of kidney function.  
Neutrophil migration into injured tissue is driven by surface proteins on endothelial 
cells and neutrophils.  Generally, selectins (e.g. E-selection) on endothelial cells (ECs) 
interact with the P-selectin, PSGL1, on neutrophils as they roll along ECs.  This interaction 
stimulates adherence through neutrophil integrins.  These integrins bind to endothelial 
ICAM-1 and ICAM-2 upregulated by proinflammatory cytokines such as IL-1β. Neutrophils 
may then crawl along the endothelial cells until identifying an EC junction.  Once at an EC 
junction, vascular permeability is increased through an ICAM-1/2 dependent signaling 
cascade that leads to the turnover of the tight junction protein VE-Cadherin.  Extravasation 
is somewhat of a misnomer in that migration of neutrophils through the EC layer can be 
tightly sealed with Rho dependent actin rings forming at the site of neutrophil diapedesis.  
Migration into the tissue further requires transiting the basement membrane and spaces 
between pericytes to the site of injury.  In some cases, this could be hundreds of microns 
away(28). 
In the kidney there are at least two major flavors of capillary beds-glomerular and 
peritubular.  Neutrophils associate with EC in both beds and only extravasate in peritubular 
capillary beds. Neutrophil adherence/tethering in glomeruli is driven by PSGL1-selectin 
and integrin-ICAM-1 complex formation and is reinforced by patrolling monocytes.  
Neutrophils and monocytes together lead to glomerular inflammation and injury.  In the 
peritubular capillary beds, the same molecular players are present, with additional 
stimulus from cytokines (tissue and neutrophil derived) and the injury dependent 
upregulation of CD44 on neutrophils that facilitates extravasation via VAP-1 on 
pericytes(76). 
In sterile injury, such as acute kidney injury (AKI) it is thought that neutrophils are 
recruited to the damaged tissue directly by damage associated molecular patterns 
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(DAMPs) and by chemokines released by injured cells and resident immune cells.   
Neutrophils recognize DAMPs, including histones, DNA, n-formyl peptides, etc. in a toll 
like receptor dependent manner(74).  Neutrophils are also recruited to sites of injury and 
inflammation by chemokines and lipid signaling molecules released by tissue resident 
immune cells and damaged tissue cells (e.g. keratinocytes, and endothelial and epithelial 
cells). For instance, in humans the neutrophilic chemokines CXCL8, CXCL1, CXCL2 and 
leukotriene B4 (LTB4) are made and released in the kidney following AKI.  In mice CXCL1, 
CXCL2 and CXCL3 are functional homologs of CXCL8.  Blocking CXCL1, CXCL2 or LTB4 
in mice, reduces neutrophil infiltrate, kidney injury and improves kidney function.   
Neutrophils also make a repertoire of cytokines and chemokines that can further drive an 
inflammatory response including, but not limited to, the recruitment of additional 
neutrophils, monocytes and macrophages(18, 22, 77).   
In this work neutrophil diversity in AKI is uncovered and the cytokine mechanisms 
that may be involved in driving this diversity of neutrophils and their transcriptional 
programs is elucidated. It is hypothesized that the severity of ischemic injury and 
reperfusion specifically affects a cellular response that correlates with recovery of kidney 
function. Specifically, the severity of injury affects the behaviors and census of neutrophils 
to affect recovery of kidney function.  The following work will demonstrate 1) the full 
diversity of neutrophils and their transcriptional programs associated with AKI, 2) the 
proportions of these subpopulations in AKI, 3) the impact of the severity of injury on these 
proportions and 4) a possible role for an underappreciated CXCR2 ligand.   
 
Results 
Quality of RNA libraries during ischemic injury 
Ischemia reperfusion injury of the kidney causes significant damages to the 
tubules, especially the S3 segment of the proximal tubule highlighted by a loss of 
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brushborders and necrosis (Figure 2.1).  To ensure that high-quality libraries could be 
generated from damaged tissue, the number of reads, reads per cells and the percentage 
mitochondria were compared between severe injury and a sham surgery.  The injury did 
not appear to alter the quality of the libraries (Figure 2.2 versus 1.1).   
 
Tubular epithelium expression of injury markers increases following ischemia 
To test if there is detectable injury in the kidney, vibratome sections were stained 
with the injury marker KIM-1(Havcr1) and the brush border(F-actin) marker phalloidin, and 
imaged by confocal microscopy. KIM-1 staining was detected in a subset of proximal 
tubule S3 segments following 6 hours of reperfusion after severe or moderate ischemia 
(Figure 2.1).  Furthermore, the two injuries can be discerned by microscopy.  This would 
suggest that transcriptionally there should be an indication of injury in the tubular 
epithelium.  The normalized and scaled expression matrices from whole-kidney single-cell 
isolations after severe and moderate injury and ~6 hours of reperfusion were aligned with 
the Sham dataset described in chapter 1.  Cluster labels from chapter 1 were also 
transferred.  With ischemia there was an expected increase in immune cells, most 
significantly neutrophils (Figure 2.3).  These will be discussed in detail below.   
The expression level of tubular injury markers in the epithelium of injured versus 
sham surgery was used to assess tubule damage with moderate and severe injury (Figure 
2.4).  As expected, there was Kim-1/Havcr1 expression, albeit very low, in the S3 of the 
proximal tubules.  There was also expression of Lcn2 (NGAL) in the LOH and intercalating 
cell-a of the collecting duct.  This is similar to a previous report with a mouse Lcn-reporter 
strain that identified Lcn2 expression in the LOH and intercalating cells of the CD(78).  
Although with ischemia there was an increase in injury marker expression, it was harder 
to differentiate between the two ischemia times. Lastly, the expression levels of the pro- 
and anti-apoptotic genes, Bax and Bcl-2, respectively, were tested.  As with the injury 
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markers, there was little difference between moderate and severe injury and in some cells-
types there was little difference between sham and injury (Figure 2.4). 
 
Functional changes in the epithelium induced by injury. 
Different lengths of ischemia are expected to change the transcriptional programs 
of the tubular epithelium as blood flow drops, nutrients fall, and metabolic by-products rise. 
To characterize the cellular response of the kidney epithelium to ischemic injury, pathway 
analysis comparing the injured epithelial cells to the uninjured epithelial cells was 
performed on the whole kidney isolation.  Positive differentially expressed genes of 
clusters from individual tubule types, were analyzed by pathway analysis in ReactomePA 
or by using clusterProfiler (79).  
 
Endothelium.   
The endothelium, after a sham surgery, is expressing genes for pathways 
associated with metabolism including glycolysis, oxidative phosphorylation and 
gluconeogenesis.  With moderate injury this shifts to a population of cells that has 
upregulated pathways associated with toll-like receptor (TLR) regulation and Rho GTPase 
driven NADPH Oxidase activity (Figure 2.5).  After severe injury, the endothelium does 
not change significantly except for a hint of TLR regulation (Figure 2.5). 
 
Sub-segments of the nephron.   
The proximal tubule is damaged in ischemic AKI.  With severe injury, brush borders 
are lost, and necrosis is visible in the outer stripe of the medulla-where the S3 segment is 
found (Figure 2.1).  The S1 subsegment was, at baseline, expressing a suite of 
transporters and maintaining cell-cell contacts and communication.  Following moderate 
injury there was little change.  After severe injury there were still few changes-only an 
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indication of TLR pathway upregulation (Figure 2.6A).   The S2 segment was metabolic 
at baseline but responded to the ischemia with stress pathways and readying cell division 
through dissolution of the centrosome and regulation of the cell cycle (Figure 2.6B).  The 
S3 segment was like the S1 segment at baseline and had an abundance of transporters 
upregulated.  After moderate, the S3 segment transitioned to pathways associated with 
ECM organization including the assembly of collagen fibrils.  For both moderate and 
severe injury the S3 segment had upregulation of TLR pathways (Figure 2.6C).  Like the 
S1, the S3 segment also upregulates a suite of transporters after injury.  Cells of the LOH 
and DCT respond to the increasing time of ischemia by upregulating pathways associated 
with the extracellular matrix (Figure 2.7).  Of note was an upregulation of apoptotic 
pathways in the DCT and CD-PC after ischemic injury (Figure 2.8B, and 2.9).   
Intercalating cells did not significantly upregulate pathways in either moderate or severe 
injury.  
 
Injury induced expansion of immune cells 
To determine how ischemic injury affects recruited immune cells, the relative 
percentage of immune cells from injured CD45+ enrichment isolations was calculated 
(Figure 2.10 and 2.11).  As expected, the CD45+ enrichment yielded more neutrophils, 
NK cells and macrophages (Figure 2.10 and 2.11).    The monocyte populations increased 
dramatically following the moderate 22-minute IRI.  Compared to the 30-minute IRI, there 
was also more NK cells in the 22-minute IRI.  In contrast to the 22-minute IRI, there was 
a dramatic increase in infiltrating pro-inflammatory Ly6chi monocyte/macrophages after 
30-minutes of ischemia (Figure 2.11).   
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Injury expands neutrophil subtypes in a severity of injury dependent manner 
To determine if ischemic injury alters the sub-populations of neutrophils recruited 
to the kidney, neutrophils were taken from the whole kidney and CD45+ enriched datasets 
from the different ischemic injuries and sham condition and aligned with Seurat.  To 
facilitate downstream analyses, this was combined with cells classified as neutrophils from 
whole blood single cell isolation for both ischemic times (Figure 2.12).    The whole blood 
isolation contained clusters of neutrophils with Hbb-bt expression.   This suggests they 
may be cells that have phagocytosed red blood cells.  To avoid hemoglobin contributing 
to the identification of neutrophil subtypes associated with the kidney, these cluster were 
excluded.  After combining these datasets and processing in Seurat, the number of 
neutrophil clusters expanded from the four described in chapter 1 to fourteen 
transcriptionally defined neutrophil populations (Figure 2.12).  
A new marker panel was generated from conserved genes to address the new 
clusters of neutrophils (Figure 2.13).  Some of the neutrophil populations described in 
chapter 1 were uncovered in the combined dataset.  For instance, the cystatin homolog 
BC100530 is a marker for cluster 7 and was a marker for cluster 1 in chapter 1(Figure 
2.13).   Overall, several novel populations were added with the inclusion of both the blood 
and injury scRNASeq datasets.   New group of cells expressing markers of MHC I antigen 
presenting or MHC II antigen presenting markers were detected and clustered in cluster 
11 or 8 respectively.   Even with the removal clusters with high hemoglobin transcript as 
described above, cells that may have phagocytosed RBCs, based on the preponderance 
of hemoglobin transcripts, were detected in cluster 12-a cluster found predominantly in the 
blood preparations (Figure 2.13).  Based on both their position in UMAP space (Figure 
2.14) and their expression of common markers (Figure 2.15),  it is possible that clusters 
1,6,4,2,5 and 13 are a continuum of the same or similar neutrophils from less-activated 
(low Ltf and Camp) to active and transmigration competents (high Ltf, Camp, Prok2, 
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Cd177 and Mmp8).  CXCR2 ligands, Ccrl1 and Il1b were highly expressed in cluster 9 
and 3-cytokine rich populations.  To control for MDSC contamination, the new clusters 
were checked for Cd84 and Agr2 expression.  Of the 14 clusters, cluster 6 had higher 
levels of these markers and may represent MDSC cells.  Based on these analyses, 
working classifications were defined for the 14 clusters and a sort order was established 
to align putative connectedness between the clusters (Figure 2.13 and Table 2.1).   
To test if neutrophil subpopulations are sensitive to the severity of injury, the 
fraction of each cluster in the sham surgeries and the ischemic injuries were compared 
(Figure 2.14).   Cluster 8 (antigen presenting), a cluster of cells enriched for transcripts 
involved in antigen presentation was found in its greatest proportion with 22-minute IRI.  
In contrast cluster 13 (activated), is a cluster expressing Ltf (a marker of activated 
neutrophils) mostly associated with 30-minute IRI (Figure 2.13).   
 
The kidney affects neutrophil subtype proportions and transcriptional programs 
The microenvironments of the kidney are expected to induce specific population 
of neutrophils, as seen in cancer and cardiac ischemia.  Following ischemia, the fraction 
of Cluster 8, 9 and 10 is high in the kidney and negligible in the blood (Figure 2.14).  This 
suggests these populations may be induced by the kidney milieu and are not readily found 
in the blood. 
The transcriptional program of the neutrophil subpopulations may also be sensitive 
to the kidney milieu.  To test for this, pathway analysis with ReactomePA was performed 
on the combined neutrophil dataset in two ways.  The first approach determined the 
markers of a given cluster relative to the other clusters within a condition and compared 
those upregulated pathways for clusters between conditions (e.g. in the blood versus in 
the kidney, Tables 2.2 and 2.3).  The second was to ask how a given cluster was different 
between two conditions (e.g. in the blood versus in the kidney Tables 2.5 and 2.6).   As 
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the two ischemia times may also alter the transcriptional state of neutrophils in the blood, 
a differential expression and ReactomePA analysis was performed to assess changes in 
circulating neutrophils between the different lengths of ischemia as well.  As expected, the 
upregulated pathways of the 14 clusters from neutrophils in the blood were different than 
those isolated from the kidney (Tables 2.2 and 2.3).  More striking though, was the change 
in pathways in neutrophils associated with the kidney when comparing the two ischemia 
times.  Neutrophils from across multiple clusters with 22-minute IRI were expressing 
genes associated with antigen presentation, pattern recognition and IL-1 signaling (Table 
2.2).  This contrasts with neutrophils from 30-minute IRI, who were expressing genes 
associated with reactive oxygen detoxification and/or E-selectin and vascular wall 
interaction, with minimal antigen presentation and IL-1 signaling (Table 2.3).  Directly 
comparing the two ischemia times further demonstrates the unique effect moderate and 
severe injury have on upregulated pathways in neutrophil clusters.  In 22-minute IRI 
multiple clusters are upregulating antigen processing pathways, in contrast to 30-minute 
IRI in which platelet activation was upregulated in many clusters (Table 2.4). 
To assess how a specific population changes once in the kidney each cluster was 
also directly compared to itself between the blood and the kidney.  These analyses 
demonstrate a further shift in the transcriptional program of each neutrophil cluster and 
shows that these changes are sensitive to the severity of the ischemic injury (Tables 2.5 
and 2.6).  Comparing between neutrophil clusters localized to the blood or after 22-minute 
or 30-minute IRI, neutrophils in the blood where broadly upregulating Rho GTPase 
pathways suggesting motile neutrophils (Table 2.5 and 2.6).  Neutrophils prepared from 
the kidney following 22-minute IRI, consistently upregulated TLR pathways and to a lesser 
degree vascular wall interaction pathway (Table 2.5).  With 30-minute IRI, the neutrophils, 
across clusters, either upregulated metabolism or detoxification of reactive oxygen 
pathways and increased pathways involving interactions with the vascular wall by E-
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selectins (Table 2.6).  As with the previous analysis the kidney milieu dramatically impacts 
the transcriptional program.  Furthermore, the transcriptional program was uniquely 
impacted by the degree of injury. 
  
Recruitment of neutrophils to the injured kidney via the CXCR2 axis  
The recruitment of neutrophils to injured tissue is dependent upon a combination 
of cytokine signaling and pattern-recognition.  In ischemic AKI there is a clear requirement 
for ligands of the CXCR2 cytokine axis(44, 46, 80-82).  To test for an association of 
CXCR2 signaling with the recruitment of neutrophils and determine probable source(s) of 
this signaling, the expression of CXCR2 ligands was assessed in cells isolated from the 
kidney.  This included transcripts for the CXCR2 ligands Cxcl1, Cxcl2 and Cxcl3 (Cxcl5 
was not detected in these data, Figure 2.15).  As expected Cxcl1 and Cxcl2 are expressed 
in several cellular compartments with 22-minute IRI.  The highest Cxcl2 expressing cells 
were neutrophils followed by macrophages, neither of which expressed Cxcl1 (Figure 
15A). There was low expression of Cxcl1 in epithelial cells of S1 and S3 subsegments of 
the proximal tubule and in the intercalating cells of the collecting duct (Figure 2.15B).  
With 30 minutes of ischemia injury the neutrophils continued to be the highest expressing 
cells.  Additionally, in contrast to 22-minute IRI, S1, S2 and S3 subsegments of the PT 
and the LOH expressed Cxcl2.  Surprisingly, there was an increase in Cxcl1 and Cxcl2 
transcript in ~20% of the secretory granular cells of the juxtaglomerular apparatus-both 
were expressed above the levels in other subsegments of the nephron including the S3 
segment of proximal tubule (Figure 2.15B). 
After 30 minutes of ischemic injury there was an unexpected expression of Cxcl3 
in ~30% of neutrophils (Figure 2.15A).  Expression of Cxcl3 by specific neutrophil clusters, 
was investigated in neutrophils from the kidney.  Cxcl3 was most highly expressed in 
neutrophil clusters 3, 9 and 11 with intermediate levels in clusters 6, 0, 10, 7 and 12 
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(Figure 2.16B). There was robust expression of Cxcl2 and Cxcl3 in cluster 9, irrespective 
of severity of injury, suggesting a cytokine active population of neutrophils.  The 
expression of Cxcl3 in response to severe injury and in specific neutrophil subtypes 
suggests a unique role for Cxcl3 in signaling with CXCR2 in severe AKI. 
Neutrophils in AKI share markers with neutrophils in cancer 
If the neutrophil clusters defined here are robust and significant, they should be 
detectable in other mouse datasets, especially pathologies expected to include 
neutrophils.  To test this, a publicly available scRNASeq dataset from a mouse model of 
breast cancer metastasis was processed in Seurat and clusters identified(58).  These 
clusters were screened with the neutrophil panel described in Figure 2.13 to identify 
similar neutrophils populations in AKI and cancer (Figure 2.17).  The neutrophil clusters 
identified in cancer were 0,1,2,4,6 and 8 (Figure 2.17), most closely resemble the AKI 
super-cluster defined by 1,2,4,5 and 13 (Figure 2.12 and 2.13).  Furthermore, the 
remaining cluster in the cancer dataset, had analogous populations in AKI (Figure 16B 
and A).   The putative motile (cluster 7 in AKI) and antigen presenting (cluster 8 in AKI) 
had similar population in cancer (clusters 5 and 7 respectively).  Cluster 3 in AKI and 
cancer also appear similar yet expression of Cd84 and Arg2 in the cancer cluster suggest 
these are the G-MDSC described previously(58). 
 
Discussion 
There was little difference in expression of injury makers between the two ischemia 
times.  For instance, less than 20% of the S3 segment of the proximal tubule upregulated 
Havcr1 (KIM-1) although it was detectable by confocal microscopy as well as obvious 
differences in tubular necrosis between the two ischemia times.  Lcn was upregulated in 
tubule subsegments-similar to previous reports-but did not discriminate between the two 
ischemia times. This would suggest either 1) the epithelium has not reacted differently to 
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the increased tissue damage, which is unlikely given the tubular necrosis seen by 
microscopy, or 2) that these markers are not sufficient for discriminating between the 
damage caused by the two different ischemia times.  To explore the later possibility, 
pathway analysis was used to uncover differences in the transcriptional program between 
a sham surgery and injury.  From these analyses, it was clear that the epithelium has 
responded by changing the complement of solute transporters, increasing pattern 
recognition pathways via TLR and NADPH oxidases and altering interactions with the 
extracellular cellular matrix.  Thus, although the injury markers did not discriminate 
between the injury times, a combination of genes changing points to transcriptional shifts 
in the tubular epithelium that correlate with ischemia time.  At least at this early time point, 
6 hours after reperfusion, this illustrates the difficulty of developing biomarkers especially 
those that can give an indication of how much injury has occurred. 
 Neutrophil diversity was detected in the blood of injured mice and the kidneys of 
both injured and uninjured mice.   There were neutrophil subpopulations specific to either 
the blood, kidney, or both.  Furthermore, the kidney milieu drives additional transcriptional 
differentiation of neutrophils resulting in clear phenotypic differences between the 
neutrophils isolated from the blood versus the kidney.  These differences are further 
exacerbated by the severity of ischemic injury.  In severe injury, 30 minutes of ischemia, 
neutrophils are primed for transmigration, detoxifying a damaged tissue and are activating 
platelets.  Additionally, cluster 9, a source of CXCR2 ligands and cluster 13, putative 
activated neutrophils, are proportionally increased in severe injury vs sham or moderate 
injury.  Thus, in severe injury there is both increased signaling for infiltration via CXCR2 
and an increase in activated neutrophils.   With moderate injury, the neutrophils are 
expressing pattern recognition genes and pathways associated with antigen presentation.  
Furthermore, cluster 8, a cluster of cells enriched with transcripts for antigen presentation 
are found in the greatest numbers after the moderate injury.  This suggests that these 
   
49 
 
neutrophils may be important in moderate injury.  For instance, these neutrophils may limit 
damage through sensing with pattern receptors and modulating further immune response, 
such as NK infiltration, with antigen presentation pathways.  Thus, a further 8 minutes of 
ischemia is sufficient to cause tissue damage that dramatically shifts the neutrophil 
response in terms of diversity and transcriptional programs. 
The striking difference in the transcriptional states of neutrophils found in the 
kidney between the two ischemic times suggested there may be significant differences in 
cytokine and chemokine signaling.  When comparing CXCR2 signaling between the two 
ischemic times Cxcl2 is found in both IRIs and in Sham surgery, while a second ligand, 
Cxcl3 is uniquely detected with the longer ischemia times.  This suggests that Cxcl2 and 
Cxcl3 are acting together in severe injury.  Perhaps, when both are present, neutrophils 
are more likely to infiltrate the kidney and lead to further tissue damage. Interestingly, this 
ligand is expressed almost exclusively in a subset of neutrophils.  This suggests a role for 
a previously underappreciated CXCR2 ligand that is produced by a subset of neutrophils. 
However, these findings have two important limitations: we do not know 1) how much of 
this transcript is translated into active cytokines and 2) what the effect of 20% of proximal 
tubules expressing CXCR2 ligands versus most of the infiltrating neutrophils? For 
instance, by a multiplexed bead assay, CXCL2 was upregulated after severe injury and 6 
hours of reperfusion versus a sham surgery-suggesting the complexity is not fully address 
by these data(83).  Confirming the importance of Cxcl3 in CXCR2 signaling and neutrophil 
recruitment during AKI will require further exploration of these cytokines in the kidney 
using microscopy and/or a multiplexed bead assay and neutralization experiments. 
The origin of CXCR2 ligands changed between ischemia times.  In both injuries, 
the highest expression is in neutrophils and secondly, macrophages.  Importantly, CXCR2 
ligands are also coming from the epithelium. What was unexpected was a shift in sources 
of CXCR2 ligands in the epithelium.  With 22-minute IRI the ligands were expressed in the 
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proximal tubule.  With 30-minute IRI, the expression dramatically shifted to the secretory 
granular cells of the juxtaglomerular apparatus.  This suggests an unappreciated role for 
specialized granular cells and the juxtaglomerular apparatus in responding to ischemic 
injury via expression of neutrophilic chemokines. Furthermore, although the expression of 
the cytokines was low in the granular cells (relative to neutrophils), the juxtaglomerular 
apparatus is poised to modulate immune cell recruitment (neutrophils) and modulate 
filtration and hemodynamics of the nephron.  Understanding how the juxtaglomerular 
apparatus might function in this role could be important to uncovering new therapeutics at 
the junction of immunomodulation and hemodynamics of the kidney. 
Ly6chi-monocyte/macrophage and the novel Monocyte-1 population are the most 
dramatic shifts in populations in severe and moderate injury, respectively. Although not 
elaborated here, their preponderance suggests an important role in the recovery of kidney 
function.   Ly6chi-monocyte/macrophages are traditionally thought of as pro-inflammatory-
in contrast to Ly6clo-monocyte/macrophages which are patrolling and involved in tissue 
repair(84).  The correlation of a pro-inflammatory monocyte/macrophage with 30-minute 
IRI is not unexpected.  The behavior and nature of this novel monocyte/macrophage 
population, monocyte-1, is unclear.  With this dataset, it is possible to test for monocyte 
chemokines such as Ccr2 ligands, and co-conspirators to unravel this mechanism as was 
done here with putative role of Cxcl3 in neutrophil recruitment in AKI. 
The neutrophil diversity associated with AKI and the kidney is striking.  This work 
is the first unbiased holistic description of neutrophil transcriptional and functional diversity 
in the kidney.  Based on similarities in cluster markers and pathway analysis across the 
neutrophils there appears to be two major “super-clusters” comprised of sub clusters and 
a number of additional neutrophil clusters with specialized functions.  The first “super-
cluster” is composed of clusters 0,3,9 and 10 and the second is composed of clusters 
1,4,5 and 13.  From these data, the first “super-cluster” is a source of CXCR2 signaling 
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while the later “super-cluster” is reminiscent of a classically active neutrophil.  These two 
“super-clusters” are joined by 6 ancillary clusters that have specific activity (e.g. cluster 8 
and 11 are antigen presenting via MHCII or MHCI respectively and cluster 7 is motile).  It 
is especially exciting that two of the neutrophil populations identified in AKI are also 
present in a mouse model of cancer.  This suggests 1) the neutrophil diversity detected 
here is reproducible, and 2) these data have enough breadth and depth to capture 
neutrophil types seen in an orthogonal disease.  The correlation of the clusters described 
here with outcomes in AKI suggests the complex etiologies of AKI may be founded in our 
poor understanding of the complexity of neutrophil biology.  The neutrophil as the early 
hunter-killer belies their phenotypic complexity and their mechanistic impact in disease.     
 
Methods 
Animal handling and surgeries.   
 All surgeries were performed in compliance with institutional review and under 
approved protocols.  Ischemic injury of mouse kidneys was performed as indicated in 
Chapter 4. 
 
Isolation of single cells from injured kidneys   
 Isolation of total kidney and CD45+ enriched cells in injured kidneys was 
performed as given in chapter 1.  For total kidney isolations two kidneys from one male 
were used as starting material.  For CD45+ enriched cells, 3 kidneys were isolated from 
two male mice with 22 min ischemic time and reperfusion for 6 hours and 4 kidneys were 
isolated from two male mice following 30 min ischemia and reperfusion for 6 hours.   
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Isolation of immune cells from blood for scRNASeq  
 Immune cells for scRNASeq were isolated from blood from mice following 
ischemic injury for either 22 or 30 minutes after six hours of reperfusion.  ~1.5 mL per 
condition, or ~700 uL per animal whole blood was sampled by a jugular bleed.  The blood 
was immediately mixed with 5 mL 1x Red blood cell (RBC) lysis buffer and incubated for 
10 min at room temperature and diluted with 8mL 1XPBS+1%FBS.  Cells were pelleted 
by centrifugation at 0.4 x g for 7 minutes and resuspended in 5 mL of RBC lysis buffer.  
The pellet was lysed three more times for a total of 4 rounds of lysis.  After the final 
pelleting the cells were washed in 8 mL 1XPBS+1%FBS before resuspension in 300 µL 
1XPBS+1%FBS and processed for 10x in the genomics core. 
 
Bioinformatics  
 Seurat analysis was performed as outlined in Chapter 1 with Seurat v 3.1.  
Scripts and code are available via github.  Pathway analysis was performed in 
ReactomePA.  Gene lists were generated in Seurat using either FindConservedMarkers 
for assessing a common phenotype across genetic and injury conditions or with 
FindMarkers with different subset selections to achieve comparisons as indicated.  To 
facilitate multiple comparison clusterProfiler was used with gene lists as well.  Gene lists 
for differential expression analysis and used in pathway analyses were filtered for 1) a 
threshold of significance of p < 0.05 with and without corrections for multiple comparisons 
(as indicated in the text) and 2) ribosomal proteins were removed by gene name prior to 
pathway analysis.  Tables of ReactomePA pathways were manually curated based on 1) 
the ~top 50% of gene ratios  (fraction of genes in ReactomePA pathway represented in 
genelist) or gene hits 2) an adjusted p-value > 0.05 (in most cases it was > 0.01) and 3) 
dismissal of highly ranked metabolic or transcriptional pathways if criteria 1 and 2 could 
be met.   




Generation of figures.   
 Plots and graphs were generated in R with Seurat, ReactomePA or custom 
scripts (stacked bar plots) unless otherwise noted.   
 
Data availability.  
 Raw and processed data will be made available online at GEO hosted by the 








Figure 2.1. Morphological indications of kidney injury.   A. Examples of IRI experiment 
with either 22- or 30-minutes of ischemia and 6 hours of reperfusion in wild-type mice.  
Sections were stained for Ly6G and KIM-1 and with phalloidin and DAPI and imaged by 
confocal microscopy.  Insets at bottom show the injury marker KIM1 (asterisk) and loss of 
brushborder (pound). In small fields at right arrows indicate neutrophils in capillaries (blue) 
and clustering in the interstitium (red), loss of brushborders (green) and casts (cyan). 










Figure 2.2.  Quality control metrics in injured tissue. Total cells were isolated from 
mouse kidneys after 30-minute ischemia and 6 hours of reperfusion, processed on the 
10X Chromium platform, and expression tables created.  The expression tables were 
analyzed in the R package Seurat v 3.1.   The number of RNAs detected 
(nFeatures_RNA), the number reads per RNA (nCount_RNA) and the percentage of 
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Figure 2.3.  UMAP plot of all cells from whole kidney.  Cells from were isolated from 
kidneys after sham surgery, 22- or 30-minutes of ischemia and 6 hours of reperfusion, 
processed for 10X chromium library generation, sequenced, and processed as indicated 
in the methods.  Individual cells have been quality controlled, removing high count 
libraries/cells and those with excessive mitochondrial transcripts.  Clustering identified 26 
populations of cells.  These cells were classified by cluster based on collated markers 
(Figure 1.5).  Cells from the two ischemia surgeries and the sham surgery were plotd 
separately to show the cells recovered in each of the conditions by cell-type.  
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Figure 2.4.  Injury and apoptosis marker expression in the kidney following 
ischemic injury.  Injury and apoptotic marker indicate changes in kidney cells following 
ischemia.  The proapoptotic marker Bax and anti-apoptotic marker Bcl2 expression levels 
are given at left.  The injury markers Cd44, Lcn (N-GAL) and Havcr1 (KIM-1) are given at 
right.  Expression level is by color and the fraction of cells expressing the gene is indicated 
by the size of the dot (scales as indicated). 
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Figure 2.5. ReactomePA analysis of endothelium.  Differential expression analysis was 
performed between endothelium in the sham surgery versus both injury condition and for 
either injury condition versus the sham surgery.  The differentially expressed genes were 
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Figure 2.6. ReactomePA analysis of proximal tubule subsegments.  Differential 
expression analysis was performed between tubular epithelium in the sham surgery 
versus both injury condition and for either injury condition versus the sham surgery.  The 
differentially expressed genes were limited to increased expression and corrected 
(Bonferroni) p-values <0.05.   




Figure 2.7. ReactomePA analysis of loop of Henle and distal convoluted tubule.  
Differential expression analysis was performed between tubular epithelium in the sham 
surgery versus both injury condition and for either injury condition versus the sham 
surgery.  The differentially expressed genes were limited to increased expression and 
corrected (Bonferroni) p-values <0.05.   
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Figure 2.8. ReactomePA analysis of connecting tubules and collecting duct 
principal cells.  Differential expression analysis was performed between tubular 
epithelium in the sham surgery versus both injury condition and for either injury condition 
versus the sham surgery.  The differentially expressed genes were limited to increased 
expression and corrected (Bonferroni) p-values <0.05.   






Figure 2.9. ReactomePA analysis of collecting intercalating cells A.  Differential 
expression analysis was performed between tubular epithelium in the sham surgery 
versus both injury condition and for either injury condition versus the sham surgery.  The 
differentially expressed genes were limited to increased expression and corrected 
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Figure 2.10.  UMAP projection of classified immune cells from sham and injury 
surgeries.  Cells from CD45+ enrichment of sham and injured kidneys were processed 
for scRNASeq to generate expression.  The individual matrices were normalized, scaled, 
aligned, cluster identified and plotted in the same UMAP plot.  The 22-minute ischemia 














Figure 2.11.  Distribution of immune cells in response to ischemia reperfusion 
injury.  Immune cells from CD45+ enrichment isolation form 22- and 300minute IRI and 
sham surgery were tabulated, and fractions of total cells calculated.  Total immune cells 













Figure 2.12.  UMAP of neutrophils isolated from kidneys after sham and injury.  
Neutrophils from whole kidney, CD45+enrichment, and blood isolation were combined into 
one dataset.  Each dataset was individually normalized prior to alignment and 
recalculation of principal components.  Neutrophils from whole kidney were preprocessed 
with more stringent QC parameters to facilitate combining with neutrophils from the blood 
and the CD45+ enrichment isolation.  New clustering identified 14 clusters of neutrophils.  
Neutrophils from the whole kidney isolation and the CD45+ enrichment isolation are given 
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Figure 2.13.  Markers of neutrophil subpopulations.  Differential expression analysis 
on the 14 clusters was performed and markers for populations were curated. The 
neutrophil cluster were separated into two “super-clusters” and five additional clusters 
based on this marker analysis.  The first super-cluster was composed of clusters 1,4,2,5 
and 13 and the second included 0,3,9 and 10.  Of the five remaining, 4 resembled clusters 
previously identified (this work) and the fifth, cluster 6, may represent an MDSC population 
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Figure 2.14.  Distribution of neutrophil subpopulations is sensitive to compartment 
and severity of injury.  Neutrophil populations from all datasets (Sham conditions from 
whole kidney were excluded due to low yield of neutrophils) were ordered by neutrophil 
super cluster comprised of 1,4,2,5 and 13, separated by clusters 7,8,11,12 and the second 
super cluster comprised of 0,3,9 and 10.  The number of cells per cluster were tabulated 
and the fraction of totals calculated.  The total number of cells per condition is given above 
each column.  Specific populations are poorly represented in the blood isolations (black 
and orange pounds and black asterisks).  Specific populations are upregulated by 22- and 
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Figure 2.15.  Expression analysis of CXCR2 ligands.  Neutrophils and macrophages 
express CXCR2 ligands with sensitivity to the severity of injury.  Using the combined whole 
kidney dataset and selecting the 22- or 30-minutes of IRI Cxcl1, Cxcl2 and Cxcl3 
expression level was plotted on a dot plot where intensity represents level of expression 
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and size of dot indicates the fraction of the cell-type expressing the transcript.  A.  Plotting 
all cell types.  B.  Selecting only cell-types from the nephron demonstrates lower levels of 
expression in the proximal tubule and secretory granular cells (Gran. cells) of the 
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Figure 2.16.  Injury affects Cxcl3 and Cxcl2 expression by neutrophil clusters.  Cxcl2 
is consistently expressed across ischemia conditions and the sham while Cxcl3 is uniquely 
expressed after ischemia.  A.  Expression level of cytokines was plot as the color of each 
cell plotted in a UMAP plot.  Cells are from both ischemic injuries and the sham.  B.  Cxcl3 
transcription is uniquely sensitive to ischemic injury.  Chemokine expression for all cells in 
each subpopulation (cluster) was plotted by cluster number per ischemia condition or the 
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Figure 2.17.  Neutrophils from a breast cancer metastasis model mirror population 
identified in AKI.  A publicly available dataset was downloaded from GEO (GSM4131336 
and GSM4131337) and processed in Seurat.  A.  The clusters identified in the cancer 
dataset were screened with the markers identified for neutrophils in AKI.  Clusters 
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2,6,0,1,8 and 4 are like the activated super-cluster seen in AKI while clusters 7, 5, and 3 
are like clusters 8,7 and 3 in AKI (green annotation at left).  B.  UMAP plot of cells in the 
































Table 2.1. Working Neutrophil Definitions  
transcriptionally related clusters are color coded 
Cluster Description Markers 
0 
Primed Srgn 
    
1 
Primed-Infiltrating Prok2 
  Srgn 
2 
Infiltrating Prok2 
  Cd177 
3 
Signaling-Infiltrating Srgn 
  Il1b 
4 
Infiltrating Prok2 
    
5 
Infiltrating Prok2 
  Mmp8 
6 
Infiltrating Prok2 
  Srgn 
7 
Motile Gm5483 
  BC100530 
8 
Antigen Presenting (MHC II) Cd74 
    
9 
Cytokine Active Cxcl2 
  Cxcl3 
10 
Metabolic mt-Atp6 
    
11 
Antigen Presenting (MHC I) H2-T23 
  Isg15 
12 
Phagocytic Hbb-ba 
    
13 
Activated Ltf 
  Ly6c2 






Table 2.2.  Pathways upregulated by neutrophil clusters within the blood 
or kidney with 22-minute IRI      
Cluster 
Blood 22min IRI (versus 
other IRI clusters) 
kidney 22min IRI (versus other 
kidney 22min IRI clusters) 
Markers 
0 
IL-4, IL-13 signaling IL-1 signaling Srgn 
IL-1 signaling 
Class II MHC antigen 
presentation   
1 
Siliac acid metabolism Dectin-1 pattern recognition Prok2 
  RUNX2 myeloid differentiation Srgn 
2 
Anti-microbial peptides RUNX2 myeloid differentiation Prok2 
  GTSE1 G2/M progression Cd177 
3 
IL-1 signaling E-Selectin interactions Srgn 
Secretory granule packing 
Cell surface interaction vascular 
wall Il1b 
4 
Motility TLR trafficking Prok2 
Infiltration Dectin-1 pattern recognition   
5 
Rho GTPase signaling IL-1 signaling Prok2 
Detoxification of Reactive 
Oxygen TLR signaling Mmp8 
6 
Golgi trafficking Interleukin signaling Prok2 
Formyl peptide signaling Response to hypoxia Srgn 
7 
Golgi trafficking IL-1 signaling Gm5483 
  Antigen processing presentation BC100530 
8 
PF4 minimize NET size IL-1 signaling Cd74 
Platelet pathways Antigen processing presentation   
9 
IL-1 signaling IL-1 signaling Cxcl2 
TLR7,8,9 Antigen processing presentation Cxcl3 
10 
Mitochondrial Dectin-1 pattern recognition mt-Atp6 
  IL-1 signaling   
11 
Class I MHC antigen 
presentation Antigen processing presentation H2-T23 
IL-1 signaling C-Lectin receptors Isg15 
12 
RBC Phagocytic Interleukin signaling Hbb-ba 
  C-Lectin receptors   
13 
Antigen presentation C-Lectin receptors Ltf 
Regulation of Metabolism Dectin-1 pattern recognition Ly6c2 






Table 2.3.  Pathways upregulated by neutrophil clusters within the blood or 
kidney with 30-minute IRI 
Cluster 
Blood 30 min IRI (versus 
other Blood 30 min IRI 
clusters) 
kidney 30 min IRI (versus other 
kidney 30 min IRI clusters) 
Markers 
0 
Ccl3,4,6 Detoxification of reactive oxygen Srgn 
IL-1 signaling E-Selectin interactions  
1 
Formyl peptide signaling Antigen processing presentation Prok2 
Ccl6 signaling RUNX2 myeloid differentiation Srgn 
2 
Anti-microbial peptides TLR signaling Prok2 
  Cell response to stress Cd177 
3 
Interleukin signaling Detoxification of Reactive Oxygen Srgn 
TLR47,8,9 E-Selectin interactions Il1b 
4 
Ccl6 signaling Detoxification of Reactive Oxygen Prok2 
  E-Selectin interactions  
5 
Rho GTPase signaling Detoxification of Reactive Oxygen Prok2 
Detoxification of Reactive 
Oxygen TLR signaling Mmp8 
6 
Apoptosis Detoxification of Reactive Oxygen Prok2 
  Cell response to stress Srgn 
7 
Cystatins GTSE1 G2/M progression Gm5483 
  Cell response to stress BC100530 
8 
PECAM-1 and intergin 
interaction Detoxification of Reactive Oxygen Cd74 
Cell surface interaction 
vascular wall TLR signaling  
9 
CXCR2 signaling Cell response to stress Cxcl2 
  
Cell surface interaction vascular 
wall Cxcl3 
10 
PIP3 and AKT signaling E-Selectin interactions mt-Atp6 
PTEN regulation 
Cell surface interaction vascular 
wall  
11 
Class I MHC antigen 
presentation Cell response to stress H2-T23 
  IL-1 signaling Isg15 
12 
RBC Phagocytic Detoxification of Reactive Oxygen Hbb-ba 
  E-Selectin interactions  
13 Rho GTPase signaling 
Detoxification of Reactive 
Oxygen Ltf 
  Cell response to stress Ly6c2 




Table 2.4. Pathways differentially upregulated by cluster in the kidney  
between ischemic injuries 
Cluster 
Kidney 22 min IRI (versus 
kidney 30 min IRI) 
Kidney 30 min IRI (versus 
kidney 22 min IRI) Markers 
0 
RUNX3 expression TLR signaling Srgn 
Antigen cross presentation Rho GTPase Signaling  
1 
RUNX2 transcriptional reg. Rho GTPase Signaling Prok2 
Metabolism Platelet activation Srgn 
2 
Metabolism NS Prok2 
 Antigen cross presentation  Cd177 
3 
Metabolism Metabolism Srgn 
    Il1b 
4 
RUNX3 expression Platelet activation Prok2 
Metabolism Interleukin signaling  
5 
Dectin signaling Platelet activation Prok2 
 Endosomal TLR response Interleukin signaling Mmp8 
6 
Translation Platelet activation Prok2 
Antigen cross presentation Interleukin signaling Srgn 
7 
NS MAPK signaling Gm5483 
  Interleukin signaling BC100530 
8 
Dectin signaling Metabolism Cd74 
 C-type lectin receptors  Cellular response to stress  
9 
Interleukin signaling Rho GTPase Signaling Cxcl2 
 Class I MHC antigen 
processing   Cxcl3 
10 
Antigen processing-cross 
presentation Rho GTPase Signaling mt-Atp6 
Class I MHC antigen processing    
11 
Antigen processing-cross 
presentation Rho GTPase NADH Oxidase H2-T23 
RUNX2 transcriptional reg.   Isg15 
12 
Antigen processing-cross 
presentation NS Hbb-ba 
C-type lectin receptors    
13 
RUNX2 transcriptional reg. ROS and RNS production Ltf 
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Table 2.5. Pathways differentially upregulated by cluster when in the blood 
versus the kidney with 22-minute IRI 
Cluster 
Blood 22 min IRI (versus 
kidney) kidney 22 min IRI (versus blood) Markers 
0 
Integrin signaling Metabolism Srgn 
      
1 
Integrin signaling TLR signaling Prok2 
  MHCII antigen presentation Srgn 
2 
Rho GTPase signaling Detoxification of reactive oxygen Prok2 
Programmed cell death   Cd177 
3 
Metabolism Metabolism Srgn 
  Inflammasome Il1b 
4 
Rho GTPase signaling TLR signaling Prok2 
Integrin signaling     
5 
Rho GTPase signaling Chemokine receptor binding Prok2 
    Mmp8 
6 TLR signaling 
Cell surface interactions vascular 
wall Prok2 
  E-Selectin interactions Srgn 
7 
Cell-cell communication TLR signaling Gm5483 
Rho GTPases activate 
oxidases   BC100530 
8 
Integrin signaling Cellular response to heat stress Cd74 
Rho GTPase signaling TLR signaling   
9 
Rho GTPases activate 
oxidases TLR signaling (4/7/8/9) Cxcl2 
    Cxcl3 
10 
Autophagy Metabolism mt-Atp6 
      
11 
 Pattern recognition Metabolism H2-T23 
   Isg15 
12 
Scavenge receptors TLR signaling (3/2/5/6/7/8/9) Hbb-ba 
Heme uptake     
13 
Pattern recognition Metabolism Ltf 
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Table 2.6. Pathways differentially upregulated by cluster when in the blood 
versus the kidney with 30-minute IRI 
Cluster Blood 30 min IRI (versus kidney) kidney 30 min IRI (versus blood) Markers 
0 TLR signaling 
Cell surface interactions vascular 
wall Srgn 
TNF-alpha and beta production    
1 
MHC I antigen presentation Detoxification of reactive oxygen Prok2 
TLR signaling (7/8/9) 
Cell surface interactions vascular 
wall Srgn 
2 
Integrin signaling TLR signaling Prok2 
  Detoxification of reactive oxygen Cd177 
3 
Immunoregulatory (lymphoid) TLR signaling Srgn 
  E-Selectin interactions Il1b 
4 
TLR signaling Detoxification of reactive oxygen Prok2 
Death Receptor signaling Metabolism  
5 
Rho GTPase signaling/effectors Detoxification of reactive oxygen Prok2 
  TLR signaling Mmp8 
6 
Autophagy Detoxification of reactive oxygen Prok2 
 TLR signaling Srgn 
7 
TLR signaling (7/8/9) E-Selectin interactions Gm5483 
  Detoxification of reactive oxygen BC100530 
8 
NS NS Cd74 
     
9 
Metabolism Metabolism Cxcl2 
    Cxcl3 
10 
Rho GTPase signaling and 
effectors Metabolism mt-Atp6 
MAPK signaling    
11 
pro-survival NFkB signaling Detoxification of reactive oxygen H2-T23 
MAPK signaling   Isg15 
12 
Rho GTPase signaling Metabolism Hbb-ba 
MAPK signaling    
13 
Rho GTPase signaling Metabolism Ltf 
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Chapter 3.  Uromodulin dependent change in neutrophil transcriptomes 
 
Introduction 
Uromodulin (Tamm-Horsfall protein, THP) is made solely in the kidney(85).  
Specifically, it is made in the thick-ascending limb of the Loop of Henle (LOH).  A large 
fraction is secreted into the urine where it forms oligomers and fibers.  These oligomers 
have been shown to play a role in controlling urinary tract infection and act as a sink for 
cytokines in the lumen of kidney tubules(86). Soluble THP monomer is secreted 
basolaterally where it has immunomodulatory activity(46).  Within the kidney, basolateral 
secreted THP modulates myeloid cells through regulation of the IL17/IL23 axis(83, 87). 
Systemically, THP has further effects on myeloid cells and neutrophils by regulating 
granulopoiesis.  In a THP knock-out (THP-/-) mouse there is systemic neutrophilia-a state 
of increased circulating neutrophils (87).  Compared to wild-type mice, the THP-/- mouse 
is sensitive to kidney injury and shows poor recovery of kidney function after ischemic 
injury(75).   
A THP knock-out (THP-/-) mouse strain is susceptible to severe ischemic injury.  
With wild-type mice 30 minutes of ischemia results in significant injury to the kidney(75).  
In a THP-/- mouse this damage is exacerbated with increased tubular destruction in the 
outer stripe and loss of S3 proximal tubules, a shift to necrotic vs apoptotic cell death and 
a decrease in kidney function (serum creatinine levels).  This damage is accompanied by 
an increase in neutrophil infiltrates in THP-/- mice.  Functionally, by serum creatinine 
levels, a shorter ischemic time, 22 minutes, better mimics the 30 minutes of injury in wild-
type mice.  Importantly, with the shorter ischemic time there is still a significant increase 
in neutrophils infiltrating the kidney compared to a sham surgery or wild-type mice.  I am 
poised with an intervention (22 minutes of ischemia) and the knock-out mice to better 
understand the role of THP in modulating neutrophil polarization in the injured kidney. 
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Compared to a wild-type mouse, the milieu of the injured kidney in the THP-/- 
mouse is severely dysregulated.  After 22-minutes of ischemia the cytokine profile shows 
distinct dysregulation at 6, 24, and 48 hours after injury.  This includes transient pro-
inflammatory cytokines at 24 hours and the absence of anti-inflammatory cytokines at 48 
hours seen in wild-type mice(83). It is hypothesized that this altered chemokine and 
cytokine profile will correlate with the polarization of neutrophils early (6h) in injury.  This 
work will demonstrate that dysregulation of the tubular epithelium, immune cells and 
cytokine signaling in the absence of THP correlates with a change in neutrophils including 
the upregulation of pathways associated with complement cascade, cellular senescence 
and death pathways leaving the kidney more susceptible to AKI. 
 
Results 
Validation of THP-/- and effects of gene knockout 
The THP knock-out mouse used in these studies is a knock-out for exons 1-4 and 
a small fragment of the THP promoter.  As such, THP transcript should not be detectable 
by scRNASeq.  The THP transcript was not detected in the whole kidney isolation datasets 
from THP-/- mice (Figures 3.1 and 3.2).  This contrasts with detectable signal of THP in 
the putative LOH clusters in the wild-type mice after sham surgery (Figures 3.1 and 3.2). 
 
Neighboring gene regulation in the THP-/- mouse 
scRNASeq provides a unique opportunity to test for polar effects, the effect of the 
knockout on expression of neighboring genes, in the THP-/- mouse.  To assess the 
transcriptional change in neighboring genes, scRNASeq data for genes neighboring THP 
was compared between sham surgeries in knock-out versus wild-type mice (Figure 3.1).  
As expected, there is no THP transcript detected in the THP-/- mouse and it was detected 
   
81 
 
robustly in the LOH and DCT in the wildtype mouse.    Of the four neighboring genes, only 
Acsm2 was detected in both the wild-type and knockout mouse.  Acsm2 is acyl-coenzyme 
A synthetase involved in fatty acid metabolism not known to have an immunomodulatory 
role or affect granulopoiesis.  The expression of Acsm2 is similar between the wild-type 
and mutant mice.  Of note is the decrease in Acsm2 expression the proximal tubules sub-
segments, LOH and DCT (Figure 3.2).  This suggests a mild polar effect on Acsm2 may 
exist in the THP-/- mouse. 
 
Functional differences of kidney epithelium in THP -/- mice 
The loss of THP and its role in tubular crosstalk with the S3 segment suggests that 
there may be functional changes in the tubular epithelium of the kidney.  To test this, first, 
epithelial and endothelial cells from the whole kidney THP-/- mice were mapped to the 
subsegment clusters identified in chapter 1.  With these cells, pathway analysis was 
performed on genes differentially expressed between THP-/- and wild-type mice to assess 
changes in the transcriptional programs of these subsegments.  Strikingly, the 
endothelium has a pro-inflammatory profile with upregulation of interferon alpha and beta 
pathways while also expressing genes involved in MHC I antigen presentation.  The 
proximal tubule, LOH and collecting duct expressed new sets of solute transporters as 
compared to tubule subsegments from wild-type mice.  Lastly, the connecting network 
tubular epithelium activated a suite of mitotic entry pathways suggesting a subsegment 
undergoing active mitosis (Table 3.1). 
 
Changes in kidney epithelium during injury in THP -/- mice 
Like wild-type mice after 30-minutes IRI, THP -/- mice recover poorly from AKI.  
Thus, it is expected that the THP-/- mice would have a kidney epithelium like the wild-type 
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mice after 30-minutes IRI (Chapter 2).  Instead, after 22-minutes of IRI in THP-/- mice the 
kidney epithelium shifted to pathways driving and responding to extracellular matrix and 
TGFβ signaling (Table 3.1). 
 
Monocyte/macrophages distribution in THP-/- mice is altered  
Myeloid cells are dysregulated in the THP-/- mouse(83, 87).  The myeloid cells are 
similarly dysregulated in these data.  In the CD45+ enrichment isolation from THP-/- mice 
after a sham surgery, the resident monocyte/macrophages have expanded with an 
apparent loss of Ly6chi monocytes versus the sham surgery in wild-type mice.  With injury 
the expansion is reminiscent of severe injury in wild-type mice, but not to the same extent 
as over half of the immune cells isolated in THP-/- mice were neutrophils (Figure 3.3). 
 
Neutrophil distribution in THP -/- mice is like wild-type mice with moderate injury  
To test if THP plays a role in regulating the diversity of neutrophils, neutrophils 
from THP-/- mice the combined CD45+ enriched and kidney isolation dataset were aligned 
to the wild-type data (Figure 3.4).  All the neutrophil clusters were detected in the THP-/- 
mouse and 2 clusters were over-represented (3 and 8).  An expansion in cluster 8 was 
similar to the expansion seen with a 22-minute IRI in wild-type mice, suggesting the 
neutrophil populations may be already responding to a kidney milieu unlike what is found 
in the wild-type mouse and possibly similar to 22-minute IRI (Figure 3.5).  In contrast to 
wild-type mice, Cluster 5 is lost in THP-/- mice without injury suggesting, that Cluster 5 is 
dependent upon THP expression in the kidney. 
 
   
83 
 
Neutrophils in THP -/- mice are uniquely primed for tissue damage 
The transcriptional programs of the neutrophils may change even if the diversity of 
neutrophils was not affected by the absence of THP.  To test for this possibility, pathway 
analysis with ReactomePA was performed on the combined CD45+ enriched and kidney 
isolation datasets comparing neutrophil populations between THP-/- and wild-type mice.  
The transcriptional programs of the neutrophils in the THP-/- mice upregulated pattern 
recognition pathways via TLR and complement cascade pathways (Table 3.2).  The 
preponderance of complement cascade pathways was not seen in any wild-type IRI.  
 
Injury in THP-/- mice expands specific neutrophil subtypes  
The THP-/- mouse is sensitive to AKI.  THPs role in granulopoiesis argues that in 
AKI, THP may modulate neutrophil subpopulations either by altering the distribution of 
neutrophils or by altering the transcriptional program of neutrophils.  To test for the 
possibility that the distribution of neutrophil populations is altered in the absence of THP 
during injury, neutrophils from a 22-minute IRI in THP-\- mice were tabulated by 
subpopulation.  This relative distribution was compared to both wild-type ischemia for 22- 
or 30-minute IRI in the CD45+ enriched samples and between blood and kidney isolations 
(Figure 3.5 and 3.6).  Following 22-minute IRI, there was further expansion of cluster 8-
the antigen presenting population (versus THP-/- sham, Figure 3.4).  There was also an 
expansion of population 3 a putative member of the cytokine signaling super cluster in the 
CD45+ enrichment isolation but not in the whole kidney isolation (Figure 3.5).  Like injury 
in wild-type mice, the neutrophils isolated from the kidney versus the blood were enriched 
for cluster 8 and 9.  The putative cluster 10 did not appear to be enriched in the kidney as 
seen in wild-type mice after injury (Figure 3.6 and Figure 2.14). 
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Toll-like receptor signaling and complement cascade pathways after injury in THP-/- mice 
The kidney epithelium of THP-/- mice is oxidative relative to wild-type mice(88).  
This environment is expected to specifically alter upregulated pathways in neutrophils.  
When comparing the upregulated pathways for a given cluster between the blood and 
kidney after injury, neutrophils in THP-/- mice upregulated pattern-recognition pathways, 
and most dramatically, toll-like receptor (TLR) pathways (both TLR4 and TLR7/8/9) and 
complement cascade.  The upregulation in TLR signaling and complement cascades in 
multiple neutrophils subpopulations suggests, irrespective of a neutrophil’s presumptive 
phenotype (antigen presentation, motile, etc. Table 2.1), the kidney milieu is causing a 
dramatic shift in the transcriptional program across neutrophil subpopulations (Table 3.3 
and 3.4).   
 
CXCR2 axis is dysregulated in THP-/- mice versus wild-type mice  
In wild-type mice after 30-minute IRI the combination of Cxcl2 and Cxcl3 correlates 
with a change in the distribution of neutrophil subpopulations, neutrophil transcriptional 
pathways, and poor recovery of kidney function.  To test if there is a similar correlation of 
CXCR2 activation, neutrophil transcription and recovery of kidney function, in THP-/- mice, 
the expression level of CXCR2 ligands was assessed in neutrophils following 22-minute 
IRI from THP-/- mice.  In the THP-/- mouse following 22-minute IRI, neutrophils expressed 
CXCR2 ligands-including Cxcl2 and Cxcl3.  There was also Cxcl1 expression in the S1 
and S3 subsegments of the proximal tubule.  In THP-/- mice there is CXCR2 ligand 
expression similar to 30-minute IRI (Cxcl3 expression) and 22-minute IRI (Cxcl1 
expression in the proximal tubule) in wild-type mice (Figure 3.7A). Approximately 20% of 
the neutrophils after IRI THP-/- mice are expressing Cxcl3.  The neutrophil clusters 
primarily expressing Cxcl3 included 6, 3,9,10 and 11(Figure 3.7B).   These are some of 
the same clusters expressing Cxcl3 after 30 minutes of ischemia in wild-type mice (Figure 
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2.16B). The clusters not expressing Cxcl3 include 0, 7 and 12.  Of these, cluster 12 was 
not detected after injury (it is more abundant in blood specimens, Figure 2.14). 
 
Discussion 
The kidney environment was altered in the absence of THP.  For instance, the 
subsegments in the THP-/- mouse express solute carriers and transporter pathways 
distinct from the wild-type mouse.  The pathways upregulated in neutrophils were also 
dramatically affected by the absence of THP. 
TLRs are a first line of defense when the immune system is faced with either 
pathogens or tissue damage.  TLR pathways may act as gate keepers of further immune 
system activation and thus play a role in immunomodulatory processes.  After ischemic 
AKI in THP-/- mice TLR4 is expressed on proximal tubule cells(75).  In the case of 
ischemia in THP-/- mice, the large swing towards TLR signaling in neutrophils suggests 
that TLR signaling may be responding to significant tissue damage or possibly that THP 
normally, and beneficially, represses TLR expression (the absence of TLR4 is protective 
in AKI(89)).  
The upregulation of complement cascade pathways, especially prior to injury, was 
unique to the neutrophils isolated from THP-/- mice.  It seems likely complement cascade 
pathways play a significant role in the sensitivity of the THP-/- mouse to AKI.  In chapter 
2, in wild-type mice, there was a correlation between an increase in cluster 8 (putative 
MHCII antigen presenting cluster) and 22-minute IRI and thus better recovery of kidney 
function.  Here, in THP-/- mice, this cluster is likewise increased but the sensitivity to AKI 
remains.  If cluster 8 is better for recovery of kidney function as the data in wild-type mice 
suggested, then perhaps it is no match for the upregulation of complement cascades seen 
in the THP-/- mice.  It should be noted that cluster 8 also upregulates complement cascade 
pathways in THP-/- mice.  Thus, by pathway analysis there was uniformity in the response 
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of neutrophils in the kidneys of THP -/- mice not seen in wild-type mice after 22-minute 
IRI.   
CXCR2 signaling in the THP-/- mouse had characteristics of both moderate and 
severe injury in wild-type mice.  There was robust Cxcl1 expression in the S1 and S3 
segments of the proximal tubule after 22-minute IRI in the THP-/- mouse, as seen in wild-
type mice after 22-minute IRI.  In contrast to 22-minute IRI in wild-type mice, Cxcl3 was 
expressed by neutrophils in THP-/- mice after 22 minutes of ischemic injury.  Furthermore, 
cluster 3, which expands in injury is also expressing Cxcl3 after injury.   Cxcl3 was only 
detected in wild-type mice with 30-minute IRI (Chapter 2).    Lastly, a low level of Cxcl1 
expression was seen in granular cells.  Thus, CXCR2 signaling was dysfunctional as 
compared to wild-type mice and had characteristics of both ischemia injury times tested 
here in wild-type mice.  This suggests that THP may modulate CXCR2 signaling by 
repressing Cxcl3 and Cxcl1 in specific cell types possibly via repression of the IL17/IL23 
axis(90). 
In the absence of THP the mouse kidney is a stressed environment, as suggested 
by the high levels of oxidation in the cortex of the THP-/- kidney and systemically(88).  In 
these data, this environment correlated with upregulation of complement cascade 
pathways in neutrophils.  In injury these neutrophils may cause or be primed to cause 
significant tissue damage.  This is combined with dysregulated CXCR2 ligands that drive 
more neutrophils into the tissue(90).  Thus, a two-hit mechanism of neutrophil behavior 
and cytokine dysregulation may lead to the increased sensitivity to AKI of the THP-/- 
mouse. 
THP was required for modulating the distribution of neutrophils without IRI.  After 
IRI it was less important as the distribution of neutrophil following 22-minute IRI in the 
THP-/- mice was like what was seen in wild-type mice following 22-minute IRI.  However, 
the kidney milieu (e.g. chemokines) was altered as illustrated by Cxcl1, Cxcl2 and Cxcl3 
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expression more like the expression pattern of CXCR2 ligands after severe injury in wild-
type mice.  Furthermore, the transcriptional programs and pathways of neutrophil 
subpopulations were shifted to TLR signaling and complement cascade pathways 
irrespective of the putative neutrophil subpopulation.  This suggests that THP may have a 
global effect on neutrophil behavior, via the kidney milieu(88) and granulopoiesis(90), 




Animal handling and surgeries   
 All surgeries were performed in compliance with institutional review and under 
approved protocols.  Ischemic injury of mouse kidneys was performed as indicated in 
Chapter 4. 
 
Isolation of single cells from injured kidneys   
 Isolation of total kidney and CD45+ enriched cells in injured kidneys was 
performed as given in chapter 1.  For total kidney isolations two kidneys from one male 
were used as starting material.  For CD45+ enriched cells, 4 kidneys were isolated from 
two male THP -/- mice with 22 min ischemic time and reperfusion for 6 hours and 4 kidneys 
were isolated from two male THP -/- mice following a sham surgery.    
 
Isolation of immune cells from blood for scRNASeq   
Immune cells for scRNASeq were isolated from blood from THP-/- mice following 
ischemic injury for 22 after six hours of reperfusion.  ~700 uL per animal and from two 
animals’ total whole blood was sampled by a jugular bleed.  The whole blood was 
processed as outlined in Chapter 2. 




Data availability  
 Raw and processed data will be made available online at GEO hosted by the 
National Center for Biotechnology Information. 
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Figure 3.1.  THP transcript is not detected in the THP-/- mouse.  UMAP plots of single 
cells from sham and 22-minutes IRI in THP-/- mice and sham surgery from wild-type mice 
was color-coded by cell for expression level of THP.  There wasn’t any expression of THP 
in the knock-out mouse 
 




Figure 3.2.  Exploring polar effects in the THP-/- mouse. Of the genes neighboring 
THP(Uromodulin) only one had detectable levels of transcript in the whole kidney 
isolations-Acsm2.   Acsm2 has a mild polar effect in the LOH and distal segments of the 


















Figure 3.3. The distribution of immune cells is sensitive to the presence of THP.  All 
immune cells from CD45+ enrichment isolation of wild-type and THP-/- mice were 
tabulated and plotted.  THP is required for baseline infiltration of Ly6chi macrophages 
(blue asterisks) and regulating the number of resident macrophages (orange asterisks).  
Ly6chi-macrophages expand in injury in THP-/- mice (black asterisk). The total cells 










Figure 3.4.  The distribution of neutrophils is modulated by THP.  Neutrophils from 
either knock-out or wild-type sham surgeries were tabulated by neutrophil cluster.  The 
relative proportion of cluster 0 and 8 goes up in the absence of THP (black asterisks) and 
the proportion of cluster 2 goes down (orange asterisks).   The total number of cells per 
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Figure 3.5. Injury in THP-/- mice affects the distribution of neutrophils.  Neutrophils 
from either knock-out or wild-type sham surgeries were tabulated by neutrophil cluster 
from either whole kidney or CD45+ enrichment isolations separately.  Cluster 8 is 
consistently upregulated after injury in THP-/- mice versus severe injury in wild-type mice 
(blue asterisks).  Cluster 3 expands in the CD45+ enrichment isolation (green asterisks).  










Figure 3.6.  Distribution of neutrophil subpopulations is sensitive to the 
compartment in THP-/- mice.  Neutrophils from knock-out sham or 22-minute IRI 
surgeries were tabulated by neutrophil cluster.  The relative proportion of cluster 9 and 8 










Figure 3.7.  CXCR2 signaling in the THP-/- mouse after ischemic kidney injury.  Using 
whole kidney isolations from THP-/- mice, CXCR2 ligands Cxcl1, Cxcl2 and Cxcl3 (Cxcl5 
was not detected) were tested for expression level in both sham surgery and after 22-
minutes of ischemia and 6 hours or reperfusion.  A. A dot plot of the expression levels-
scale as indicated.  Surgical interventions are labeled and colored for 22-minutes IRI (blue) 
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or a sham surgery (green).  B. Expression level of CXCR2 ligands in neutrophil 
subpopulations in a 22-minute IRI or sham surgery.  Specific neutrophil subpopulations 



























Abbreviations:  Endo. = endothelium: PT = proximal tubule; LOH = loop of Henle, Gran. 
Cells = granular cells of the juxtaglomerular apparatus; DCT = distal convoluted tubules; 
CNT = connecting tubules; CD-PC = collecting duct principal cells, -ICa or -ICb = 




Table 3.1. Exemplar ReactomePA pathways in THP-/- mice 
Cluster 
THP -/- Sham surgery(versus wt 
Sham surgery) 
+22 minutes IRI (versus THP -/- 
Sham surgery) 
Endo. Class I MHC I antigen presentation 
Signaling by receptor tyrosine 
kinases 
Interferon-alpha/beta Platelet signaling 
PT-S1 
Amino acid transport Integrin interactions 
Protein phosphorylation   
PT-S2 
ND RhoGTPase signaling 
  GTSE1 in G2/M transition 
PT-S3 
Amino acid transport Cellular response to heat stress 
Organics transport TLR regulation 
LOH 
Ion channel transport Platelet signaling 
Protein phosphorylation ECM organization 
Gran. 
Cells 
Signaling by receptor tyrosine kinases Platelet signaling 
ECM organization ECM organization 
DCT 
ND VEGFA-VEGFR2 pathway 
  
Signaling by receptor tyrosine 
kinases 
CNT 
APC/C degradation of cell cycle 
proteins TGFbeta signaling, SMAD 
GTSE1 in G2/M transition TGFbeta signaling 
CD-PC 
Ion channel transport Cellular response to heat stress 




Signaling by receptor tyrosine 
kinases 
Hedgehog ligand biogenesis VEGFA-VEGFR2 pathway 
CD-
ICb 
mRNA splicing ND 
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Table 3.2.  Pathways upregulated in 
neutrophils from THP-/- versus wild-type 
kidneys after a sham surgery 
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Table 3.3. Pathways upregulated by neutrophil clusters in the blood or kidney 
with 22-minute IRI in THP-/- mice 
Cluster 
Blood THP-/- 22 min IRI (versus 
other Blood THP-/- 22 min IRI 
clusters) 
THP-/- kidney 22 min IRI (versus 




Ccl3,4,6 C-Lectin receptors Srgn 
IL-1 signaling IL-1 signaling   
1 
Formyl peptide signaling TLR signaling Prok2 
Ccl6 signaling   Srgn 
2 
Anti-microbial peptides Formyl peptide signaling Prok2 
  Clathrin-mediated endocytosis Cd177 
3 
Interleukin signaling Formyl peptide signaling Srgn 
Cell surface interaction vascular wall   Il1b 
4 Motility 
Detoxification of Reactive 
Oxygen Prok2 
Infiltration C-Lectin receptors   
5 
Rho GTPase signaling E-Selectin interactions Prok2 
Detoxification of Reactive Oxygen IL-1 signaling Mmp8 
6 NF-kappaB signaling 
Detoxification of Reactive 
Oxygen Prok2 
  TLR signaling Srgn 
7 
Cystatins TLR signaling Gm5483 
  TLR signaling BC100530 
8 
Platelet pathways TLR signaling Cd74 
MAPK integrin signaling     
9 
CXCR2 signaling Clathrin-mediated endocytosis Cxcl2 
TLR47,8,9 TLR signaling Cxcl3 
10 
Mitochondrial Clathrin-mediated endocytosis mt-Atp6 
  TLR signaling (7,8,9)   
11 
Class I MHC antigen presentation Cell response to stress H2-T23 
  TLR signaling Isg15 
12 
RBC Phagocytic IL-1 signaling Hbb-ba 
  TLR signaling (4,7,8,9)   
13 
Rho GTPase signaling TLR signaling Ltf 
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Table 3.4. Pathways differentially upregulated by cluster when in the blood versus 
the kidney with 22-minute IRI in THP -/- mice 
Cluster 
Blood 22 min IRI -/- mice 
(versus kidney) 




TNFR signaling TLR signaling (7/8/9) Srgn 
INFalpha/beta     
1 
Rho GTPase signaling formyl-peptide signaling Prok2 
  TLR signaling Srgn 
2 
Rho GTPase signaling Chemokine signaling Prok2 
  
Cell surface interaction at 
vascular wall Cd177 
3 
Cell division formyl-peptide signaling Srgn 
    Il1b 
4 
Rho GTPase signaling TLR signaling Prok2 
  Complement activators   
5 
Metabolism Complement activators Prok2 
    Mmp8 
6 
Death receptor signaling TLR signaling (4) Prok2 
Rho GTPase signaling Complement cascade Srgn 
7 
Rho GTPase signaling TLR signaling (4) Gm5483 
Integrin signaling TLR signaling (7/8/9) BC100530 
8 
Rho GTPase signaling TLR signaling Cd74 
Cell division     
9 
TGFβ Detoxification of reactive oxygen Cxcl2 
Integrin signaling formyl-peptide signaling Cxcl3 
10 
MAPK signaling Detoxification of reactive oxygen mt-Atp6 
IL-3, IL-5 signaling     
11 
Rho GTPase signaling Complement cascade H2-T23 
  Detoxification of reactive oxygen Isg15 
12 
NS Complement cascade Hbb-ba 
      
13 
Autophagy Peptide ligand-binding receptors Ltf 
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Chapter 4. Animal use and experimentation 
 
Animal protocols 
All protocols and procedures were under Indiana University IACUC review.  All protocol 
used for the proposed experiment was fully vetted, reviewed and approved by the Indiana 
University IACUC.   
 
Protocol 1.  Ischemia reperfusion injury surgery (adapted from T. Ashkar). 
1. Before and throughout the surgery, animals will be maintained under anesthesia using 
isoflurane. 
2. After preparation, setup and anesthesia, and under sterile conditions, the abdomen 
will be entered through a small incision.  
3. The renal pedicles will be identified, and bilateral clamps will be applied to both 
pedicles for 22 or 30 minutes.  
4. Clamps will be removed, and reperfusion of the kidneys verified visually. The 
abdominal incision will be closed in 2 layers.  
5. An analgesic (Buprenorphine 0.1mg/kg) in addition to 1-2 cc of warm saline will be 
administered subcutaneously at the end of surgery.  
6. Animals will be carefully monitored after surgery. A clinical assessment of each animal, 
noting general appearance, activity level, food intake and skin turgor will be performed 
daily.  
7. After 6 hours of reperfusion the kidneys will be harvested. Animals will be anesthetized 
with pentobarbital 130mg/kg IP, a blood specimen will be drawn, kidneys will be 
removed, and the animals sacrificed.  
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Protocol 2: Sham surgery, control for surgery and is outlined below. 
1. Before and throughout the surgery, animals will be maintained under anesthesia using 
isoflurane. 
2. After preparation, setup and anesthesia, and under sterile conditions, the abdomen 
will be entered through a small incision.  
3. The abdomen will remain open for 22 or 30 minutes.  
4. The abdominal incision will be closed in 2 layers.  
5. An analgesic (Buprenorphine 0.1mg/kg) in addition to 1-2 cc of warm saline will be 
administered subcutaneously at the end of surgery.  
6. Animals will be carefully monitored after surgery. A clinical assessment of each animal, 
noting general appearance, activity level, food intake and skin turgor will be performed 
daily.  
7. After 6 hours of reperfusion the kidneys will be harvested. Animals will be anesthetized 
with pentobarbital 130mg/kg IP, a blood specimen will be drawn, kidneys will be 




 Previous work was performed in wild-type male 129Sv/Ev (Taconic) mice at 8-10 
weeks.  Ischemia reperfusion injury (IRI) of the kidney was performed in the male mice 
exclusively because female mice are resistant to IRI (64).  Furthermore, in this work all IRI 
was performed in males to extend existing data and, for reasons that have yet to be 
elucidated, there is a sex dependent difference in susceptibility to AKI in mice.  As such, 
the experiments are intentionally performed in males only as females appear to be more 
resistant to AKI following IRI.    
 




 All animals were housed in the Indiana University animal facility-Laboratory Animal 
Resource Center (LARC).  The LARC is an AALAC accredited facility that is connected to 
our laboratory building.   The LARC employs 5 fulltime veterinarians and additional staff 
that carryout routine animal care and monitoring at least twice daily.  Mice had access to 
water ad libitum and standard chow. 
 
Limiting discomfort of animals  
 All surgeries are survival surgeries following ischemia reperfusion injury of the kidney 
or a sham surgery.  Discomfort was managed before, during and after surgery.  Prior to 
the surgery anesthesia with 5% isoflurane and low flow oxygen was used.  The depth of 
anesthesia was monitored by response to tail or toe pinch, spontaneous movements, and 
the animals’ respiratory rate.  Animals were monitored continuously before and during 
surgery.  To maintain anesthesia the isoflurane was be reduced to 1-2%. Periodically, 
every 3-4 minutes, responsiveness was tested to tail or toe pinch, and assess 
spontaneous movements and the animals’ respiratory rate.  Following all surgeries and 
twice daily until euthanasia, each animal was given a subcutaneous dose of analgesic 
(Buprenorphine HCl, 0.1 mg/Kg) to minimize post-operative discomfort.  After surgery, all 
animals were monitored every hour for 12 hours and then every 4 hours until euthanasia.  
To limit discomfort mice were monitored for not taking food for more than one day or 
minimal movement in response to stimulation on two occasions. 
 
Euthanasia  
 In surgeries, mice under sedation were exsanguinated following harvesting of tissue 
and cervical dislocation to ensure death.  This method of euthanasia is consistent with the 
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recommendations of the Panel on Euthanasia of the American Veterinary Medical 
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Summary and Conclusions 
 
Neutrophil diversity has been examined in specific disease and pathologies.   
These accounts have been limited by available techniques (e.g. microscopy and flow 
cytometry), a reliance on validated markers and the ad hoc hierarchical trees based on 
these markers and techniques.   The use of single-cell RNASeq has revolutionized our 
ability to resolve and holistically redefine populations of cells in an unbiased manner.  Here 
it is demonstrated that there is neutrophil diversity in the mouse kidney and that neutrophil 
populations respond specifically to their environment and a disease state.  The added 
complexity in neutrophil biology revealed through the novel application of these 
approaches requires a reevaluation of existing assumptions about mechanism and the 
role of neutrophils in health and disease. 
Neutrophils are more nuanced than previously appreciated.  Six transcriptionally 
distinct populations have been described in this work.  Furthermore, their putative 
behaviors, imputed by pathway analysis, were more varied than expected.   They included 
distinct immunomodulatory populations via either MHC I or MHC II mechanisms, a 
presumptively motile population, a CXCR2 signaling population and a classically activated 
population.  Two of these, the signaling and the activated populations, may be further 
subdivided (Table 2.1 and Figure 2.12).  Furthermore, specific neutrophil populations are 
uniquely sensitive to the severity of AKI (Figure 2.14 and Figures 3.4-3.5).  For instance, 
the proportion of neutrophil cluster 8 (MHC II antigen presentation) in the kidney increases 
in moderate injury and not in severe injury versus a sham surgery (Figure 2.16 and 3.5).   
These populations are not limited to AKI or the kidney.  Neutrophils like the motile and 
MHC II antigen presenting populations can be found in a mouse model of metastasizing 
cancer in the spleen (Figure 2.17).  Thus, the neutrophil diversity described here has 
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captured subpopulations of neutrophils associated with AKI and begun to define the 
landscape of common neutrophil types across tissues and disease. 
CXCR2 signaling is central to AKI.  The CXCR2 ligand Cxcl2 has been shown to 
be a major instigator of neutrophil chemotaxis in AKI and poor recovery of kidney function.  
In this work, Cxcl3, also a ligand of CXCR2, is shown to be uniquely expressed after 
severe injury in a specific set of neutrophils.  This specificity suggests a tightly regulated 
chemokine that may act in addition to Cxcl2 in severe injury.  Models of CXCR2 axis 
activity on neutrophils during AKI are given in Appendix A (Figures A.1-A.3).   
The role of THP in modulating neutrophil diversity is both nonspecific and 
finetuned.  For instance, the upregulated pathways in neutrophils were nearly uniform in 
the THP-/- mice (Table 3.2) yet there appears to be specific modulation neutrophil 
populations (Figure 3.3).  This conundrum is not new to THP.  THP has a specific role 
modulating the immune system in the kidney(83) while also having a systemic impact(87, 
88).  Furthermore, the increase in CXCR2 ligand expression in specific cell types following 
injury of THP-/- mice may be explained by THPs role in modulation of the IL17/IL23 axis.  
IL17 is known to induce upregulation of CXCR2 ligands(91).  Thus, the S1 segment of the 
proximal tubule and granular cells of the juxtaglomerular apparatus may be targets of 
THPs modulation of the cytokine milieu through the IL17/IL23 axis.      
 
Future directions 
The diversity and complexity of neutrophils proposed by this work argues for an in-
depth investigation of neutrophil biology in tissue injury.  The kidney is well suited for 
studying neutrophil diversity in normal physiology and pathophysiology as demonstrated 
by complexity of neutrophil biology during ischemic AKI.  Furthermore, neutrophils have 
been implicated in repair after tissue damage in several organs but not in the kidney.  
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Thus, there is an opportunity to expand our mechanistic understanding of a central actor 
in immunology in the complex pathologies of the kidney.  
CXCL3 is a new ligand for neutrophil recruitment that may be involved in the 
mechanistic differences between severe and moderate AKI.  Whether CXCL3 and CXCL2 
act on CXCR2 in concert, in opposition or independently to drive neutrophil recruitment 
warrants additional investigation.  First, it needs to be demonstrated that CXCL3 plays a 
significant role, like CXCL2, in the progression of AKI.  These data suggest that both 
CXCL2 and CXCL3 may act on CXCR2 to drive the severe injury seen in 30-minute IRI.  
To test for this an antibody based CXCL3 neutralization experiment could be done on 30-
minute IRI. Presumably, following CXCL3 neutralization, only CXCL2 signaling would 
remain and phenotypically the neutralized 30-minute IRI would resemble 22-minute IRI.  
Beyond this study the next avenue to pursue could include genetic testing of the origin 
and timing of both CXCL3 and CXCL2.  For instance, inducible cell-type specific knockouts 
of both CXCL3 and CXCL2 would be a malleable and powerful system for elucidating 
cytokine signaling in AKI. 
The role of atypical antigen presenting neutrophils in renal pathology is unknown.  
The putative MHC-II antigen presenting neutrophils were detected more frequently in 
moderate injury.  It is possible that they are involved in modulating the response of T-cells 
and NK cells in injured tissue.  Further elucidation of their role in AKI may provide insight 
into how severity of injury impacts recovery of kidney function.  Genetic models could 
provide a framework to selectively track (reporter strains), remove and induce behaviors 
in neutrophils.  For instance, the selective and inducible removal of neutrophil population 
8 would allow for testing of the specific requirement for these actors in AKI.   
The shifts in cytokines and distribution of differentially regulated neutrophil clusters 
with the severity of injury suggests a “one-size fits all” approach to AKI is inadequate 
(Figures A.1-2).  Thus, it is timely to explore the impact of changing both ischemia and 
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reperfusion times on injury and assaying the response of the parenchyma and infiltrating 
immune cells with single-cell sequencing, high-resolution large-scale imaging and 
multiplexed ELISAs.  This will benefit our understanding of ischemic AKI in two ways: 1) 
improve our mechanistic understanding of ischemic AKI by manipulating its two 
fundamental variables and 2) develop better models for the range of clinical ischemic AKI.  
The role of etiologies of AKI on neutrophil diversity needs to be investigated as 
well.  Experimentally, models of drug-induced AKI (cisplatin) and septic-AKI should be 
used to investigate the impact of these etiologies on neutrophil diversity and possibly 
CXCR2 signaling.  A comparative approach between ischemic, septic and drug induced 
AKI would help highlight common and unique neutrophil types and behaviors and develop 
better models of the role of neutrophil biology in AKI which, in turn, might allow for 
improved theragnostic approaches. 
This work will hopefully be a starting point for a plenitude of research projects.  This 
work provides a foundation for exploring the fundamental nature of neutrophil biology, the 
orchestration of chemokines on the CXCR2 axis and has uncovered complexity in the 
immunology of ischemic injury which may untangle the complex etiology of acute kidney 
injury. 
  





Models for neutrophil involvement in AKI with changes in the severity of injury and the 




Figure A.1. Model of cytokine activity on neutrophils with moderate injury.  CXCR2 
signaling in moderate injury is primarily from other neutrophils via CXCL2 with additional 
CXCL2 from macrophages and CXCL1 from proximal tubule epithelial cells.  





Figure A.2. Model of cytokine activity on neutrophils with severe injury.  CXCR2 
signaling in severe injury is significantly from other neutrophils via CXCL2 and CXCL3 and 
additional CXCL2 and CXCL3 from macrophages and CXCL2 from the endothelium, and 
CXCL1/2 from proximal tubule epithelium and the granular cells of the juxtaglomerular 
apparatus. 











Figure A.3. Model of cytokine activity on neutrophils with moderate injury in THP-/- 
mice.  CXCR2 signaling in THP-/- mice with moderate injury is primarily from other 
neutrophils via CXCL2 and CXCL3 and CXCL1 from proximal tubule epithelium.  The 
proposed role of THP in suppressing expression of CXCL3 and CXCL1 and in shaping 
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